<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="/resources/spdi-openaccess-jats.xsl"?>
<!DOCTYPE response [
	
<!ENTITY % article SYSTEM "http://jats.nlm.nih.gov/archiving/1.2/JATS-archivearticle1.dtd">
<!ENTITY % book-part-wrapper SYSTEM "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
	]><response><apiMessage>This XML was provided by Springer Nature</apiMessage><query>doi:10.1007/s00253-019-09697-z</query><apiKey>6b19ee21fe6a243741a528650f7c8997</apiKey><result><total>1</total><start>1</start><pageLength>1</pageLength><recordsDisplayed>1</recordsDisplayed></result><records><article dtd-version="1.2" article-type="review-article" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><?properties open_access?><front><journal-meta><journal-id journal-id-type="publisher-id">253</journal-id><journal-id journal-id-type="doi">10.1007/253.1432-0614</journal-id><journal-title-group><journal-title>Applied Microbiology and Biotechnology</journal-title><abbrev-journal-title abbrev-type="publisher">Appl Microbiol Biotechnol</abbrev-journal-title></journal-title-group><issn pub-type="ppub">0175-7598</issn><issn pub-type="epub">1432-0614</issn><publisher><publisher-name>Springer Berlin Heidelberg</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">s00253-019-09697-z</article-id><article-id pub-id-type="manuscript">9697</article-id><article-id pub-id-type="doi">10.1007/s00253-019-09697-z</article-id><article-categories><subj-group subj-group-type="heading"><subject>Mini-Review</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Function, essentiality, and expression of cytochrome P450 enzymes and their cognate redox partners in <italic>Mycobacterium tuberculosis:</italic> are they drug targets?</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="Au1"><name><surname>Ortega Ugalde</surname><given-names>Sandra</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="corresp" rid="IDs0025301909697z_cor1">a</xref></contrib><contrib contrib-type="author" id="Au2"><name><surname>Boot</surname><given-names>Maikel</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" id="Au3"><name><surname>Commandeur</surname><given-names>Jan N. M.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au4"><name><surname>Jennings</surname><given-names>Paul</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au5"><name><surname>Bitter</surname><given-names>Wilbert</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" id="Au6"><name><surname>Vos</surname><given-names>J. Chris</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1754 9227</institution-id><institution-id institution-id-type="GRID">grid.12380.38</institution-id><institution content-type="org-division">Division of Molecular Toxicology, Amsterdam Institute for Molecules Medicines and Systems (AIMMS), Faculty of Sciences</institution><institution content-type="org-name">Vrije Universiteit</institution></institution-wrap><addr-line content-type="street">De Boelelaan 1108</addr-line><addr-line content-type="postcode">1081 HZ</addr-line><addr-line content-type="city">Amsterdam</addr-line><country country="NL">The Netherlands</country></aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000000419368710</institution-id><institution-id institution-id-type="GRID">grid.47100.32</institution-id><institution content-type="org-division">Department of Microbial Pathogenesis</institution><institution content-type="org-name">Yale University School of Medicine</institution></institution-wrap><addr-line content-type="city">New Haven</addr-line><addr-line content-type="state">CT</addr-line><country country="US">USA</country></aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1754 9227</institution-id><institution-id institution-id-type="GRID">grid.12380.38</institution-id><institution content-type="org-division">Section of Molecular Microbiology, AIMMS, Faculty of Sciences</institution><institution content-type="org-name">Vrije Universiteit</institution></institution-wrap><addr-line content-type="city">Amsterdam</addr-line><country country="NL">The Netherlands</country></aff></contrib-group><author-notes><corresp id="IDs0025301909697z_cor1"><label>a</label><phone>+31 205988197</phone><email>s.ortegaugalde@vu.nl</email></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>27</day><month>2</month><year>2019</year></pub-date><pub-date date-type="pub" publication-format="print"><day>2</day><month>5</month><year>2019</year></pub-date><volume>103</volume><issue seq="1">9</issue><fpage>3597</fpage><lpage>3614</lpage><history><date date-type="registration"><day>14</day><month>2</month><year>2019</year></date><date date-type="received"><day>30</day><month>11</month><year>2018</year></date><date date-type="rev-recd"><day>8</day><month>2</month><year>2019</year></date><date date-type="accepted"><day>10</day><month>2</month><year>2019</year></date><date date-type="online"><day>27</day><month>2</month><year>2019</year></date></history><permissions><copyright-statement>© The Author(s) 2019</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p><bold>OpenAccess</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p></license></permissions><abstract id="Abs1" xml:lang="en"><title>Abstract</title><p id="Par1">This review covers the current knowledge of the cytochrome P450 enzymes (CYPs) of the human pathogen <italic>Mycobacterium tuberculosis</italic> (Mtb) and their endogenous redox partners, focusing on their biological function, expression, regulation, involvement in antibiotic resistance, and suitability for exploitation as antitubercular targets. The Mtb genome encodes twenty  CYPs and nine associated redox partners required for CYP catalytic activity. Transposon insertion mutagenesis studies have established the (conditional) essentiality of several of these enzymes for in vitro growth and host infection. Biochemical characterization of a handful of Mtb CYPs has revealed that they have specific physiological functions in bacterial virulence and persistence in the host. Analysis of the transcriptional response of Mtb CYPs and redox partners to external insults and to first-line antibiotics used to treat tuberculosis showed a diverse expression landscape, suggesting for some enzymes a potential role in drug resistance. Combining the knowledge about the physiological roles and expression profiles indicates that, at least five Mtb CYPs, CYP121A1, CYP125A1, CYP139A1, CYP142A1, and CYP143A1, as well as two ferredoxins, FdxA and FdxC, can be considered promising novel therapeutic targets.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Cytochrome P450</kwd><kwd><italic>Mycobacterium tuberculosis</italic></kwd><kwd>Redox partners</kwd><kwd>Essentiality</kwd><kwd>Stress response</kwd><kwd>Antibiotic exposure response</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution>Nederlandse Organisatie voor Wetenschappelijk Onderzoek</institution><institution-id institution-id-type="doi" vocab="open-funder-registry">http://dx.doi.org/10.13039/501100003246</institution-id></institution-wrap></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>publisher-imprint-name</meta-name><meta-value>Springer</meta-value></custom-meta><custom-meta><meta-name>volume-issue-count</meta-name><meta-value>24</meta-value></custom-meta><custom-meta><meta-name>issue-article-count</meta-name><meta-value>26</meta-value></custom-meta><custom-meta><meta-name>issue-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-holder</meta-name><meta-value>Springer-Verlag GmbH Germany, part of Springer Nature</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>article-contains-esm</meta-name><meta-value>No</meta-value></custom-meta><custom-meta><meta-name>article-numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-month</meta-name><meta-value>2</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-day</meta-name><meta-value>14</meta-value></custom-meta><custom-meta><meta-name>article-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>volume-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>journal-product</meta-name><meta-value>ArchiveJournal</meta-value></custom-meta><custom-meta><meta-name>numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-grants-type</meta-name><meta-value>OpenChoice</meta-value></custom-meta><custom-meta><meta-name>metadata-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>abstract-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodypdf-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodyhtml-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bibliography-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>esm-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>online-first</meta-name><meta-value>false</meta-value></custom-meta><custom-meta><meta-name>pdf-file-reference</meta-name><meta-value>BodyRef/PDF/253_2019_Article_9697.pdf</meta-value></custom-meta><custom-meta><meta-name>target-type</meta-name><meta-value>OnlinePDF</meta-value></custom-meta><custom-meta><meta-name>issue-online-date-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>issue-online-date-month</meta-name><meta-value>4</meta-value></custom-meta><custom-meta><meta-name>issue-online-date-day</meta-name><meta-value>12</meta-value></custom-meta><custom-meta><meta-name>issue-print-date-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>issue-print-date-month</meta-name><meta-value>4</meta-value></custom-meta><custom-meta><meta-name>issue-print-date-day</meta-name><meta-value>12</meta-value></custom-meta><custom-meta><meta-name>issue-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>article-type</meta-name><meta-value>ReviewPaper</meta-value></custom-meta><custom-meta><meta-name>journal-subject-primary</meta-name><meta-value>Life Sciences</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Microbiology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Microbial Genetics and Genomics</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Biotechnology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-collection</meta-name><meta-value>Biomedical and Life Sciences</meta-value></custom-meta><custom-meta><meta-name>open-access</meta-name><meta-value>true</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><sec id="Sec2"><title>Tuberculosis</title><p id="Par2">Tuberculosis (TB) is caused by the human pathogen <italic>Mycobacterium tuberculosis</italic> (Mtb). In 2017, 10 million new TB cases were reported worldwide and 1.3 million people died from TB infection, making it the deadliest infectious disease known to humankind (World Health Organization <xref ref-type="bibr" rid="CR127">2018</xref>). The emergence of Mtb strains resistant to the first-line anti-TB agents<italic>,</italic> i.e., ethambutol, isoniazid, pyrazinamide, and rifampicin, as well as the fatal synergy with HIV, has prompted the development and FDA approval of new drugs for TB, such as bedaquiline and delamanid. In this context, the determination of the complete genome sequence of Mtb and development of genetic tools have been instrumental in uncovering the biology of this unconventional pathogen and the identification of novel drug targets (Cole et al. <xref ref-type="bibr" rid="CR27">1998</xref>).</p><p id="Par3">The mycobacterial genome encodes a large variety of enzymes involved in lipid biosynthesis and metabolism, reflecting its elaborate capability to use lipid metabolism for both energy homeostasis and synthesis of many different components of the complex cell envelope (Gazaei <xref ref-type="bibr" rid="CR45">2018</xref>). This unusual cell envelope is critical for Mtb’s persistence, providing not only mechanical strength and protection to hostile environments but also a barrier to the entry of harmful compounds (Nikaido and Jarlier <xref ref-type="bibr" rid="CR88">1991</xref>; Chiaradia et al. <xref ref-type="bibr" rid="CR25">2017</xref>). Fortunately, because the mycobacterial cell envelope contains many unique structures, the enzymes involved in its biogenesis provide us with many Mtb-specific drug targets and thus the possibility to develop compounds that are highly specific to mycobacteria. Recent examples include the benzothiazinones that block arabinogalactan biosynthesis and delamanid that interferes with mycolic acid biosynthesis (Riccardi and Pasca <xref ref-type="bibr" rid="CR105">2014</xref>).</p><p id="Par4">Genome mapping revealed that Mtb encodes a high number of cytochrome P450 enzymes (CYPs or P450s). CYPs are haem-containing monooxygenase enzymes involved in lipid and steroid metabolism in eukaryotes. In fungi, several CYPs are already validated drug targets. An example is CYP51, the fungal sterol-14α-demethylase involved in the biosynthesis of membrane sterols. CYP51 can be inhibited by several azole-compounds (Warrilow et al. <xref ref-type="bibr" rid="CR124">2013</xref>). The use of anti-fungal azoles to inhibit CYP51 has also been proposed as treatment for parasitic infections, such as Chagas disease and the African sleeping sickness (Lepesheva et al. <xref ref-type="bibr" rid="CR70">2008</xref>; Chen et al. <xref ref-type="bibr" rid="CR24">2010</xref>). A homolog of CYP51 is also encoded in Mtb genome, <italic>cyp51b1</italic>, highlighting its potential use as a drug target. Interestingly, CYP-inhibiting azole drugs have potent anti-mycobacterial activity and econazole reduced bacterial burden by 90% in the lungs and spleen of mice infected with Mtb (Guardiola-Diaz et al. <xref ref-type="bibr" rid="CR50">2001</xref>; Ahmad et al. <xref ref-type="bibr" rid="CR4">2006a</xref>, <xref ref-type="bibr" rid="CR5">b</xref>; McLean et al. <xref ref-type="bibr" rid="CR79">2006a</xref>). However, it remains unclear whether the growth inhibition was due to inhibition of one or more Mtb CYPs by econazole (Ahmad et al. <xref ref-type="bibr" rid="CR5">2006b</xref>).</p><p id="Par5">In light of the potential role of CYPs in physiology and pathology, as well as their proven efficiency as therapeutic targets in mycobacteria, in-depth understanding of the physiological function and biochemical characterization of these enzymes is a priority. In this review, we update the current knowledge on the essentiality and physiological function of Mtb CYPs and their cognate redox partners, which has been reviewed before, adding new sections on CYP139A1 and CYP143A1 (McLean et al. <xref ref-type="bibr" rid="CR79">2006a</xref>, <xref ref-type="bibr" rid="CR81">2007</xref>, <xref ref-type="bibr" rid="CR84">2010</xref>; McLean and Munro <xref ref-type="bibr" rid="CR75">2008</xref>; Ouellet et al. <xref ref-type="bibr" rid="CR93">2010a</xref>; Ortiz de Montellano <xref ref-type="bibr" rid="CR92">2018</xref>). Furthermore, we aim to understand the regulatory network governing their expression profiles in response to various external stimuli Mtb encounters during host infection, such as nutrient depletion, hypoxia, and antibiotic exposure. We believe that the information in this mini-review will aid in assessing whether specific Mtb CYPs and redox partners are suitable candidates for the development of novel anti-TB drugs.</p></sec><sec id="Sec3"><title>The CYP family and cognate redox partners in Mtb</title><p id="Par6">The 4.4 Mb genome of Mtb H37Rv contains twenty  <italic>CYP</italic> genes (Cole et al. <xref ref-type="bibr" rid="CR27">1998</xref>). This is a relatively high number for prokaryotes, as most sequenced bacterial genomes generally contain a small number of <italic>CYP</italic> genes. The high abundance of <italic>CYP</italic> genes is a general characteristic of mycobacteria exemplified by <italic>Mycobacterium rhodesiae NBB3</italic> (70), <italic>Mycobacterium avium 104</italic> (48), <italic>Mycobacterium marinum</italic> (47), <italic>Mycobacterium smegmatis MC2</italic> (42), and <italic>Mycobacterium abscessus 47J26s/103</italic> (25) as compiled by Parvez et al. (<xref ref-type="bibr" rid="CR97">2016</xref>). In contrast, <italic>Mycobacterium leprae</italic> has lost all but one functional CYP protein, encoded by <italic>ML2088c</italic> (37% identity to Mtb CYP140A1). However, this is consistent with the overall reduction in genome size in <italic>M. leprae</italic>. Deciphering the physiological function of CYPs is usually performed through a combination of homology modeling/mapping, generation of single gene knockouts and/or biochemical characterization of the protein. Yet, despite the high abundance of CYP genes in mycobacteria, phylogenetic analysis has shown that Mtb CYPs exhibit relatively low evolutionary relationships with other species, with many bacterial species (like <italic>Escherichia coli</italic>) lacking CYPs altogether. CYP121A1, CYP128A1, CYP135, and CYP141A1 are predominantly found in mycobacteria belonging to the MTBC (Ouellet et al. <xref ref-type="bibr" rid="CR93">2010a</xref>). In addition, the overall homology between the 20 Mtb CYPs is rather low, with a maximum homology of 40% between CYP135A1 and CYP135B1 in Mtb.</p><p id="Par7">The catalytic activity of CYPs is dependent on their redox partners (McLean et al. <xref ref-type="bibr" rid="CR78">2005</xref>). CYPs are classified based on the type of redox systems they pair with. All Mtb CYPs belong to class I, meaning their catalytic activity is dependent on a NAD(P)H-ferredoxin-reductase (FNR) and a ferredoxin (Fd). Mtb encodes five ferredoxins genes, Fdx (<italic>Rv0763c</italic>), FdxA (<italic>Rv2007c</italic>), FdxC (<italic>Rv1177</italic>), FdxD (<italic>Rv3503c</italic>), and Rv1786; two FNRs namely FdrA (<italic>Rv0688</italic>) and FprA (<italic>Rv3106</italic>); and two Fd-FNR fusions, FdxB (<italic>Rv3554</italic>) and FprB (<italic>Rv0886</italic>). Fdx, FdxD, and FdxE share a common Cys-<italic>X</italic><sub>2</sub>-<italic><underline>X</underline></italic>-<italic>X</italic><sub>2</sub>-Cys-<italic>X</italic><sub><italic>n</italic></sub>-Cys-Pro iron-sulfur cluster-binding motif, where <italic>X</italic> is any amino acid and <italic>X</italic><sub><italic>n</italic></sub> indicates a number of flexible amino acids. This motif is consistent with a [3Fe-4S] cluster which is conserved on ferredoxins from other bacteria (Trower et al. <xref ref-type="bibr" rid="CR121">1993</xref>; Duff et al. <xref ref-type="bibr" rid="CR35">1996</xref>; Green et al. <xref ref-type="bibr" rid="CR48">2003</xref>; Sevrioukova <xref ref-type="bibr" rid="CR113">2005</xref>; Lu et al. <xref ref-type="bibr" rid="CR73">2017</xref>; Child et al. <xref ref-type="bibr" rid="CR26">2018</xref>). On the other hand, FdxA and FdxC resemble FdxA from <italic>M. smegmatis</italic> (<italic>MsFd</italic>), a 7Fe-ferredoxin that contains both a [3Fe-4S] and a [4Fe-4S] iron-cluster combined in a single protein (Ricagno et al. <xref ref-type="bibr" rid="CR104">2007</xref>; Ortega Ugalde et al. <xref ref-type="bibr" rid="CR90">2018a</xref>). The overall sequence identity between the [3Fe-4S] cluster-containing Mtb ferredoxins Fdx, FdxD, and FdxE is approximately 30%, whereas FprA displays approximately 40% sequence identity to the mammalian adrenoxin reductase (AdR) (Ricagno et al. <xref ref-type="bibr" rid="CR104">2007</xref>; Fischer et al. <xref ref-type="bibr" rid="CR41">2002</xref>; Ortega Ugalde et al. <xref ref-type="bibr" rid="CR90">2018a</xref>).</p></sec><sec id="Sec4"><title>Mtb CYPs and cognate redox partners essentiality</title><p id="Par8">Important information on the essentiality of certain CYPs for bacterial adaptation, growth, survival, and virulence can be obtained from transposon site hybridization (TraSH) studies. To date, several of these studies have been performed and a summary of the results for Mtb CYPs and their cognate redox partners is presented in Table <xref rid="Tab1" ref-type="table">1</xref>.<table-wrap id="Tab1"><label>Table 1</label><caption xml:lang="en"><p>Essentiality and conditional essentiality of Mtb CYPs and cognate redox partners</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"><p>Protein</p></th><th rowspan="2"><p>Gene</p></th><th colspan="5"><p>Essential (in vitro)</p></th><th colspan="6"><p>Conditionally essential for survival</p></th></tr><tr><th><p>Himar-1 transposon H37Rv strain<sup>a</sup></p></th><th><p>Himar-1 transposon H37Rv strain<sup>b</sup></p></th><th><p>Himar-1 transposon H37Rv strain<sup>c</sup></p></th><th><p>Himar-1 transposon CDC1551 strain<sup>d</sup></p></th><th><p>Himar-1 transposon H37Rv strain<sup>e</sup></p></th><th><p>Cholesterol<sup>f</sup></p></th><th><p>Macrophages<sup>g</sup></p></th><th><p>Mice spleen<sup>h</sup></p></th><th><p>Mice lungs<sup>i</sup></p></th><th><p>Guinea pigs<sup>j</sup></p></th><th><p>Primates<sup>k</sup></p></th></tr></thead><tbody><tr><td colspan="13"><p>CYPs</p></td></tr><tr><td><p>  CYP121A1</p></td><td><p><italic>Rv2276</italic></p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>ND</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td></tr><tr><td><p>  CYP123A1</p></td><td><p><italic>Rv0766c</italic></p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td></tr><tr><td><p>  CYP124A1</p></td><td><p><italic>Rv2266</italic></p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td></tr><tr><td><p>  CYP125A1</p></td><td><p><italic>Rv3545c</italic></p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>Y</p></td><td><p>N*</p></td><td><p>Y</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td></tr><tr><td><p>  CYP126A1</p></td><td><p><italic>Rv0778</italic></p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>ND</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td></tr><tr><td><p>  CYP128A1</p></td><td><p><italic>Rv2268c</italic></p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>Y</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td></tr><tr><td><p>  CYP130A1</p></td><td><p><italic>Rv1256c</italic></p></td><td><p>N</p></td><td><p>D</p></td><td><p>N</p></td><td><p>N</p></td><td><p>ND</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td></tr><tr><td><p>  CYP132A1</p></td><td><p><italic>Rv1394c</italic></p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td></tr><tr><td><p>  CYP135A1</p></td><td><p><italic>Rv0327c</italic></p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>ND</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td></tr><tr><td><p>  CYP135B1</p></td><td><p><italic>Rv0568</italic></p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td></tr><tr><td><p>  CYP136A1</p></td><td><p><italic>Rv3059</italic></p></td><td><p>GA</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td></tr><tr><td><p>  CYP137A1</p></td><td><p><italic>Rv3685c</italic></p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td></tr><tr><td><p>  CYP138A1</p></td><td><p><italic>Rv0136</italic></p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td></tr><tr><td><p>  CYP139A1</p></td><td><p><italic>Rv1666c</italic></p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td></tr><tr><td><p>  CYP140A1</p></td><td><p><italic>Rv1880c</italic></p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td></tr><tr><td><p>  CYP141A1</p></td><td><p><italic>Rv3121</italic></p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>ND</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td></tr><tr><td><p>  CYP142A1</p></td><td><p><italic>Rv3518c</italic></p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td></tr><tr><td><p>  CYP143A1</p></td><td><p><italic>Rv1785c</italic></p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td></tr><tr><td><p>  CYP144A1</p></td><td><p><italic>Rv1777</italic></p></td><td><p>N</p></td><td><p>D</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td></tr><tr><td><p>  CYP51B1</p></td><td><p><italic>Rv0764c</italic></p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td></tr><tr><td colspan="13"><p>Redox partners</p></td></tr><tr><td><p>  Fdx</p></td><td><p><italic>Rv0763c</italic></p></td><td><p>Uncertain</p></td><td><p>Short</p></td><td><p>N</p></td><td><p>N</p></td><td><p>ND</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td></tr><tr><td><p>  FdxA</p></td><td><p><italic>Rv2007c</italic></p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>ND</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td></tr><tr><td><p>  FdxB</p></td><td><p><italic>Rv3554</italic></p></td><td><p>N</p></td><td><p>D</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td></tr><tr><td><p>  FdxC</p></td><td><p><italic>Rv1177</italic></p></td><td><p>Y</p></td><td><p>Short</p></td><td><p>N</p></td><td><p>N</p></td><td><p>Y</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td></tr><tr><td><p>  FdxD</p></td><td><p><italic>Rv3503c</italic></p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td></tr><tr><td><p>  FdxE</p></td><td><p><italic>Rv1786</italic></p></td><td><p>Uncertain</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td></tr><tr><td><p>  FdrA</p></td><td><p><italic>Rv0688</italic></p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td></tr><tr><td><p>  FprA</p></td><td><p><italic>Rv3106</italic></p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td></tr><tr><td><p>  FprB</p></td><td><p><italic>Rv0886</italic></p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td><td><p>N</p></td></tr></tbody></table><table-wrap-foot><p><italic>N</italic> non-essential; <italic>Y</italic> essential; <italic>ND</italic> no data available; <italic>D</italic> contains both required and non-required regions; <italic>Short</italic> too short to call, no insertions; <italic>GA</italic> growth advantage</p><p>*Gene part of a putative operon required for survival in macrophages</p><p><sup>a</sup>DeJesus et al. <xref ref-type="bibr" rid="CR31">2017</xref></p><p><sup>b</sup>Zhang et al. <xref ref-type="bibr" rid="CR130">2012</xref></p><p><sup>c</sup>Griffin et al. <xref ref-type="bibr" rid="CR49">2011</xref></p><p><sup>d</sup>Lamichhane et al. <xref ref-type="bibr" rid="CR66">2003</xref></p><p><sup>e</sup>Sassetti et al. <xref ref-type="bibr" rid="CR109">2003</xref></p><p><sup>f</sup>Griffin et al. <xref ref-type="bibr" rid="CR49">2011</xref></p><p><sup>g</sup>Rengarajan et al. <xref ref-type="bibr" rid="CR103">2005</xref></p><p><sup>h</sup>Sassetti and Rubin <xref ref-type="bibr" rid="CR108">2003</xref></p><p><sup>i</sup>Lamichhane et al. <xref ref-type="bibr" rid="CR67">2005</xref></p><p><sup>j</sup>Jain et al. <xref ref-type="bibr" rid="CR58">2007</xref></p><p><sup>k</sup>Dutta et al. <xref ref-type="bibr" rid="CR37">2010</xref></p></table-wrap-foot></table-wrap></p><p id="Par9">The results of these studies confirm the non-essentiality of individual Mtb CYP enzymes for in vitro growth under standard laboratory conditions. This is not surprising since a high number of genes found to be essential for in vitro growth were conserved in the degenerate genome of the leprosy bacillus, <italic>M. leprae</italic> (Sassetti et al. <xref ref-type="bibr" rid="CR109">2003</xref>). Even though an initial study indicated that <italic>cyp128a1</italic> was among the essential genes unique to mycobacteria, this could not be confirmed in later TraSH studies (Sassetti et al. <xref ref-type="bibr" rid="CR109">2003</xref>; Lamichhane et al. <xref ref-type="bibr" rid="CR66">2003</xref>; Griffin et al. <xref ref-type="bibr" rid="CR49">2011</xref>; Zhang et al. <xref ref-type="bibr" rid="CR130">2012</xref>; DeJesus et al. <xref ref-type="bibr" rid="CR31">2017</xref>). These contradictory results could be due to the limited gene coverage of some of the transposon libraries. Interestingly, disruption of the orphan cyp<italic>136a1</italic> provided a growth advantage in vitro (DeJesus et al. <xref ref-type="bibr" rid="CR31">2017</xref>). Even though <italic>cyp121a1</italic> was found to be non-essential in these genome-wide transposon studies, <italic>cyp121a1</italic> could only be knocked out in Mtb H37Rv after creating a merodiploid strain. This indicates that this gene is required for growth under in vitro conditions (McLean et al. <xref ref-type="bibr" rid="CR82">2008</xref>).</p><p id="Par10">Transposon insertion studies were also conducted on bacterial cultures grown in conditions that the bacterium encounters during infection in the human host. These studies aimed to identify the mechanisms used by the bacterium to resist these insults. Griffin et al. identified <italic>cyp125a1</italic> as the sole monooxygenase essential for Mtb H37Rv growth in cholesterol, an essential carbon source during Mtb infection. Furthermore, <italic>cyp125a1</italic> was found to be essential during mouse infection (Sassetti and Rubin <xref ref-type="bibr" rid="CR108">2003</xref>). Although <italic>cyp125a1</italic> was not found to be required for macrophage infection, it is part of the <italic>fadE28</italic> locus, which is a critical operon involved in lipid transport, lipid degradation and assimilation of exogenous lipids from host cell membranes (Cole et al. <xref ref-type="bibr" rid="CR27">1998</xref>; McKinney et al. <xref ref-type="bibr" rid="CR74">2000</xref>; Rengarajan et al. <xref ref-type="bibr" rid="CR103">2005</xref>).</p><p id="Par11">Both FdxA and FdxC (the two 7Fe-ferredoxins) were found to be essential for Mtb in vitro (Sassetti et al. <xref ref-type="bibr" rid="CR109">2003</xref>; DeJesus et al. <xref ref-type="bibr" rid="CR31">2017</xref>). For FdxA, essentiality was predicted using a pathway enrichment method (Xu et al. <xref ref-type="bibr" rid="CR128">2014</xref>). Several transposon mutagenesis studies indicate that individual redox partners may not be essential under certain growth conditions, such as cholesterol rich conditions or during infection in vivo (Lamichhane et al. <xref ref-type="bibr" rid="CR66">2003</xref>; Sassetti et al. <xref ref-type="bibr" rid="CR109">2003</xref>; Sassetti and Rubin <xref ref-type="bibr" rid="CR108">2003</xref>; Lamichhane et al. <xref ref-type="bibr" rid="CR67">2005</xref>; Rengarajan et al. <xref ref-type="bibr" rid="CR103">2005</xref>; Jain et al. <xref ref-type="bibr" rid="CR58">2007</xref>; Dutta et al. <xref ref-type="bibr" rid="CR37">2010</xref>; Griffin et al. <xref ref-type="bibr" rid="CR49">2011</xref>; Zhang et al. <xref ref-type="bibr" rid="CR130">2012</xref>; DeJesus et al. <xref ref-type="bibr" rid="CR31">2017</xref>). These results could be explained by redundancy of redox partners in CYP-mediated reactions previously shown not only for Mtb (Ortega Ugalde et al. <xref ref-type="bibr" rid="CR90">2018a</xref>) but also for other bacteria, such as <italic>M. marinum</italic>, <italic>Sorangium cellulosum So ce56</italic> and <italic>Streptomyces peucetius DoxA</italic> (Ewen et al. <xref ref-type="bibr" rid="CR39">2009</xref>; Rimal et al. <xref ref-type="bibr" rid="CR106">2015</xref>; Child et al. <xref ref-type="bibr" rid="CR26">2018</xref>).</p></sec><sec id="Sec5"><title>Mtb CYPs and cognate redox partners function</title><p id="Par12">Only a handful of the 20 Mtb CYPs and cognate redox partners have been structurally and biochemically characterized. In this section, we summarize the current knowledge of the (partially) characterized Mtb CYP enzymes and associated redox partners. For a more elaborate discussion, see also (McLean et al. <xref ref-type="bibr" rid="CR79">2006a</xref>, <xref ref-type="bibr" rid="CR81">2007</xref>, <xref ref-type="bibr" rid="CR84">2010</xref>; McLean and Munro <xref ref-type="bibr" rid="CR75">2008</xref>; Ouellet et al. <xref ref-type="bibr" rid="CR93">2010a</xref>; Ortiz de Montellano <xref ref-type="bibr" rid="CR92">2018</xref>).</p><sec id="Sec6"><title>CYP51B1: the first prokaryotic sterol demethylase</title><p id="Par13"><italic>Cyp51b1</italic> was the first prokaryotic sterol demethylase gene identified in a bacterial genome. Spectroscopic analysis of the recombinant CYP51B1 showed that the P450 form rapidly converted to the P420 species. The stability of the P450 form was increased when it was bound to its cognate substrate analog estriol (McLean et al. <xref ref-type="bibr" rid="CR80">2006b</xref>; Dunford et al. <xref ref-type="bibr" rid="CR36">2007</xref>). CYP51B1 was the first Mtb CYP enzyme for which crystal structures were unraveled in the ligand-free and ligand-bound states. The enzyme was co-crystalized with azole compounds. Azoles were shown to bind with high affinity to CYP51B1, with a <italic>K</italic><sub><italic>D</italic></sub> equal to 0.18, 0.2, 0.3, and 2.1 μM for clotrimazole, miconazole, econazole, and voriconazole, respectively (Aoyama et al. <xref ref-type="bibr" rid="CR7">1998</xref>; Podust et al. <xref ref-type="bibr" rid="CR100">2001</xref>, <xref ref-type="bibr" rid="CR101">2004</xref>). Mtb CYP51B1 displayed sterol demethylase activity with lanosterol and dihydrolanosterol as substrates. In addition, the plant sterol obtusifoliol was converted to the respective 8,14-diene products when reconstituted with cognate and surrogate bacterial redox partners (Fig. <xref rid="Fig1" ref-type="fig">1</xref>) (Bellamine et al. <xref ref-type="bibr" rid="CR11">1999</xref>; Zanno et al. <xref ref-type="bibr" rid="CR129">2005</xref>). However, the relevance of this activity to mycobacterial physiology remains unclear, since the complete sterol biosynthetic pathway is lacking in Mtb (McLean and Munro <xref ref-type="bibr" rid="CR75">2008</xref>). The unknown physiological role combined with the non-essentiality may limit the suitability of CYP51B1 as a drug target in Mtb.<fig id="Fig1"><label>Fig. 1</label><caption xml:lang="en"><p>Substrates and reactions for Mtb CYP enzymes. CYP51B1 sterol demethylase catalyzes oxidative removal of 14α-methyl group from lanosterol, dihydrolanosterol, and obtusitol (Bellamine et al. <xref ref-type="bibr" rid="CR11">1999</xref>). CYP121A1 catalyzes the oxidative coupling of the two tyrosyl atoms (Belin et al. <xref ref-type="bibr" rid="CR10">2009</xref>). CYP124A1 catalyzes the ω-hydroxylation of phytanic acid and other methyl branched-chains fatty acids (Johnston et al. <xref ref-type="bibr" rid="CR60">2009</xref>). CYP125A1 and CYP142A1 catalyze the 27-hydroxylation of cholesterol (McLean et al. <xref ref-type="bibr" rid="CR83">2009</xref>; Capyk et al. <xref ref-type="bibr" rid="CR20">2009</xref>; Driscoll et al. <xref ref-type="bibr" rid="CR33">2010</xref>; Ouellet et al. <xref ref-type="bibr" rid="CR93">2010a</xref>). CYP130A1 catalyzes N-demethylation of dextromethorphan (Ortega Ugalde et al. 2018). CYP128A1 catalyzes the oxidative hydroxylation of menaquinone MK-9 (DH-2) (Holsclaw et al. <xref ref-type="bibr" rid="CR53">2008</xref>)</p></caption><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/253_2019_9697_Fig1_HTML.png" id="MO1"/></fig></p></sec><sec id="Sec7"><title>CYP121: bacterial secondary metabolism</title><p id="Par14">CYP121A1 catalyzes the formation of a carbon-carbon bond between the two tyrosyl carbon atoms of a cyclodipeptide cyclo(L-Tyr-L-Tyr) (cYY) yielding mycocyclosin (Fig. <xref rid="Fig1" ref-type="fig">1</xref>) (Belin et al. <xref ref-type="bibr" rid="CR10">2009</xref>). The physiological role of mycocyclosin for Mtb remains unknown. However, several cyclic dipeptides have been shown to have an impact on bacterial physiology. For instance, the cyclo(Phe-Pro) inhibited the production of virulence factors in <italic>Vibrio cholerae</italic> (Park et al. <xref ref-type="bibr" rid="CR96">2006</xref>; McLean et al. <xref ref-type="bibr" rid="CR82">2008</xref>, <xref ref-type="bibr" rid="CR84">2010</xref>). CYP121A1 is considered a highly selective CYP, since it does not efficiently metabolize any cYY analogs (Fonvielle et al. <xref ref-type="bibr" rid="CR43">2013</xref>). Spectroscopic characterization of recombinant CYP121A1 showed the same P450 collapse of the CO-ferrous state as previously described for CYP51B1. However, this event was reversible at lower pH, suggesting that the state was dependent on the protonation of the cysteine thiolate (Cys345) to thiol (Dunford et al. <xref ref-type="bibr" rid="CR36">2007</xref>). CYP121A1 binds with high affinity to azole drugs (<italic>K</italic><sub><italic>D</italic></sub> equal to 0.027, 0.073, 0.136, and 8.61 μM for econazole, clotrimazole, miconazole and fluconazole, respectively (McLean et al. <xref ref-type="bibr" rid="CR76">2002a</xref>, <xref ref-type="bibr" rid="CR77">b</xref>; Seward et al. <xref ref-type="bibr" rid="CR114">2006</xref>). CYP121A1-fluclonazole crystal structure (PDB 2IJ7) demonstrates that azole coordination of P450 heme can occur via a bridging water molecule, as well as directly to the iron (Seward et al. <xref ref-type="bibr" rid="CR114">2006</xref>).</p></sec><sec id="Sec8"><title>CYP124A1, CYP125A1, and CYP142A1: the cholesterol and fatty acid monooxygenase CYPs</title><p id="Par15">CYP124A1 catalyzes ω-hydroxylation reactions with a significant preference for methyl-branched lipids (Fig. <xref rid="Fig1" ref-type="fig">1</xref>) (Johnston et al. <xref ref-type="bibr" rid="CR60">2009</xref>). Several studies have shown that CYP124A1, CYP142A1, and CYP125A1 are involved in the successive oxidations of the aliphatic side chain of cholesterol and cholest-4-en-3-one at carbon position 27 to the alcohol, aldehyde, and the carboxylic acid (Fig. <xref rid="Fig1" ref-type="fig">1</xref>) (Johnston et al. <xref ref-type="bibr" rid="CR61">2010</xref>). CYP126A1 may have a related function/activity, as it shows a 37%, 36%, and 32% amino acid sequence homology with CYP124A1, CYP125A1, and CYP142A1, respectively (Ouellet et al. <xref ref-type="bibr" rid="CR93">2010a</xref>). CYP126A1 showed a strong preference for the binding of aromatics and chlorophenol moieties (Hudson et al. <xref ref-type="bibr" rid="CR56">2014</xref>). In the presence of surrogate redox partners from <italic>Spinacea oleracea</italic>, CYP124A1, CYP142A1, and CYP125A1 oxidized the cholesterol side chain to carboxylic acid. This reaction is a prerequisite for the entry of cholesterol into the β-oxidation pathway (Johnston et al. <xref ref-type="bibr" rid="CR61">2010</xref>). However, this sequential metabolic activity was not seen when several cognate redox partners were used to reconstitute the system (Ortega Ugalde et al. <xref ref-type="bibr" rid="CR90">2018a</xref>). CYP125A1 is the most efficient catalyst, followed by CYP142A1 and finally CYP124A1 (Johnston et al. <xref ref-type="bibr" rid="CR61">2010</xref>; Ouellet et al. <xref ref-type="bibr" rid="CR94">2010b</xref>). Utilization of host cholesterol as a carbon source enables Mtb to persist in macrophages and survive the harsh environment of the granuloma inside the human lung (Ouellet et al. <xref ref-type="bibr" rid="CR95">2011</xref>; Lee et al. <xref ref-type="bibr" rid="CR68">2013</xref>; Wilburn et al. <xref ref-type="bibr" rid="CR126">2018</xref>). Knockout of the intracellular growth (<italic>igr</italic>) locus (from <italic>Rv3545c</italic> to <italic>Rv3540c</italic>, which includes <italic>cyp125a1</italic>) led to accumulation of cholest-4-en-3-one, which not only prevented the growth of Mtb in cholesterol-rich medium, but also when grown with acetate, glucose and glycerol as sole carbon source (Chang et al. <xref ref-type="bibr" rid="CR21">2007</xref>, <xref ref-type="bibr" rid="CR22">2009</xref>; Frank et al. <xref ref-type="bibr" rid="CR44">2016</xref>). Hence, targeting CYPs involved in cholesterol catabolism could be a contribution to the antitubercular therapy (VanderVen et al. <xref ref-type="bibr" rid="CR122">2015</xref>).</p></sec><sec id="Sec9"><title>CYP128A1: a possible role in virulence</title><p id="Par16">Sassetti et al. initially identified <italic>cyp128a1</italic> as essential for Mtb growth in vitro<italic>.</italic> Subsequent transposon mutagenesis studies did not validate this essentiality (Table <xref rid="Tab1" ref-type="table">1</xref>). Several attempts to heterologously express CYP128A1 have been unsuccessful, preventing its biochemical and structural characterization. The operon containing <italic>cyp128a1</italic> is comprised of three genes involved in the biosynthesis of a sulfated metabolite, S881, also known as sulfomenaquinone. It was hypothesized that CYP128A1 catalyzes the required hydroxylation of dihydromenaquinone (MK-9 DH2), which is further sulfonated by a sulfotransferase (Sft3 encoded by <italic>Rv2267c</italic>) yielding S881 (Fig. <xref rid="Fig1" ref-type="fig">1</xref>) (Cole et al. <xref ref-type="bibr" rid="CR27">1998</xref>; Holsclaw et al. <xref ref-type="bibr" rid="CR53">2008</xref>). S881 is a sulfolipid (SL-1) located in the outer membrane cell wall, where it acts as negative regulator of virulence (Mougous et al. <xref ref-type="bibr" rid="CR86">2006</xref>; ten Bokum et al. <xref ref-type="bibr" rid="CR120">2008</xref>; Jackson <xref ref-type="bibr" rid="CR57">2014</xref>). Hence, assuming that CYP128A1 is indeed a quinol hydroxylase, it is an unlikely therapeutic target for Mtb.</p></sec><sec id="Sec10"><title>CYP130A1: an orphan enzyme</title><p id="Par17"><italic>Cyp130a1</italic>, as well as <italic>cyp141a1</italic>, are not required for Mtb growth in vitro. Furthermore, these genes are absent in the closely related species <italic>Mycobacterium bovis</italic>, suggesting that, if they play a role in virulence, this must be specific for Mtb. <italic>Cyp130a1</italic> is located alongside the same functional operon as <italic>Rv1258c</italic>, a gene encoding a putative tetracycline/aminoglycoside resistance (TAP)2-like efflux pump, which is upregulated treatment with tetracycline, streptomycin, erythromycin, and rifampicin (unlike <italic>cyp130a1</italic>, as discussed in section 5) and has been associated with efflux-mediated resistance in MDR-TB (Siddiqi et al. <xref ref-type="bibr" rid="CR117">2004</xref>; Morris et al. <xref ref-type="bibr" rid="CR85">2005</xref>; Jiang et al. <xref ref-type="bibr" rid="CR59">2008</xref>; Burian et al. <xref ref-type="bibr" rid="CR16">2012</xref>; Boot et al. <xref ref-type="bibr" rid="CR13">2018</xref>). Yet, no direct functional association has been reported between <italic>cyp130a1</italic> and <italic>Rv1258c</italic>. Recently, it was shown that CYP130A1 can catalyze the N-demethylation of dextromethorphan yielding 3-methoxymorphinan (Fig. <xref rid="Fig1" ref-type="fig">1</xref>) (Ortega Ugalde et al. <xref ref-type="bibr" rid="CR91">2018b</xref>). Although dextromethorphan cannot be considered a physiological substrate for this enzyme, it does provide a starting point for (1) the identification of bacterial reactions CYP130A1 may catalyze and (2) the identification of inhibitors. Nevertheless, because of the lack of comprehensive data on the impact of CYP130A1 on Mtb virulence, its potential as a drug target remains to be determined.</p></sec><sec id="Sec11"><title>CYP139A1: a possible host-response modulator and/or detoxifying enzyme</title><p id="Par18">CYP139A1 (<italic>Rv1666c</italic>) is conserved across different mycobacterium species, such as <italic>M. marinum</italic> (<italic>MMAR2475</italic>), <italic>M. bovis</italic> (<italic>Mb1694c</italic>), and <italic>M. leprae</italic> (<italic>ML1238c</italic>, pseudogene), as part of a cluster consisting of polyketide synthase genes (<italic>pks11</italic>, <italic>9</italic>, and <italic>17</italic>) and a macrolide transport ATP-binding protein ABC transporter gene. Polyketides are lipid-like molecules that are smaller than known protein toxins but have potent biological activities, such as, antibiotic (erythromycin), immunosuppressant (rapamycin), and antifungal (amphotericin B). In Mtb, the majority of the PKS-encoding genes have been linked to specific biosynthetic pathways required for the production of unique lipids or glycolipid conjugates that are critical for virulence and/or components of the organized outer membrane of the mycobacterial cell envelope. As an example, Mtb was shown to be capable of altering essential host functions by the release of polyketides that can induce a G0/G1 cell cycle arrest in the macrophages. As a result, mycobacteria are capable of challenging innate killing mechanisms and evade the adaptive immune system as non-cycling cells are less likely to be killed by cytotoxic T cells (Nishioka and Welsh <xref ref-type="bibr" rid="CR89">1994</xref>; Cumming et al. <xref ref-type="bibr" rid="CR28">2017</xref>). <italic>Pks9</italic> is an immunogenic protein (Kumar et al. <xref ref-type="bibr" rid="CR65">2011</xref>), whereas <italic>pks17</italic> (together with <italic>pks8</italic>, <italic>Rv1662)</italic> is involved in the production of methyl-branched fatty acids which are minor components of sulfolipids and acyltrehaloses (Dubey et al. <xref ref-type="bibr" rid="CR34">2003</xref>). <italic>Pks11</italic> could be involved in the assembly of alkylpyrones from fatty acyl-CoA and malonyl-CoA (Saxena et al. <xref ref-type="bibr" rid="CR110">2003</xref>; Gokulan et al. <xref ref-type="bibr" rid="CR47">2013</xref>), but the production of long-chain α-pyrone metabolites in Mtb has not been shown. Hence, CYP139A1 could play a conserved role in the modification and/or transport of these <italic>Psk</italic>-derived molecules and it could be associated with the host-pathogen interactions. On the other hand, the observation that CYP139A1 is induced after exposure to antibiotics (see below) is intriguing and may suggest a role in detoxification.</p></sec><sec id="Sec12"><title>CYP143A1: component of the ESX-5 secretion locus</title><p id="Par19">The gene encoding the orphan enzyme CYP143A1 lies adjacent to <italic>Rv1786</italic> encoding FdxE. This proximity suggests a CYP/redox partner association. Indeed, a significant binding affinity between FdxE and CYP143A1 was demonstrated with a <italic>K</italic><sub><italic>D</italic></sub> value equal to 10<sup>−7</sup> M (Lu et al. <xref ref-type="bibr" rid="CR73">2017</xref>). In Mtb and several closely related species, <italic>cyp143a1</italic> is part of the <italic>esx-5</italic> locus. Most genes of this <italic>esx-5</italic> locus are coding for substrates or components of the ESX-5 protein secretion machinery. This ESX-5 secretion system completes a multitude of functions, linked to the many different Pro-Glu (PE) and Pro-Pro-Glu (PPE) protein substrates of the system. Some of these proteins remain in the cell envelope, where they are important for modifying the cell permeability and uptake of hydrophobic carbon sources (Abdallah et al. <xref ref-type="bibr" rid="CR2">2009</xref>; Ates et al. <xref ref-type="bibr" rid="CR8">2015</xref>). In addition, Mtb ESX-5 system mediates the reduction of pro-inflammatory cytokine secretion by macrophages and induces a caspase-independent cell death in macrophages after phagosomal escape of the bacteria enabling the bacteria to infect neighboring cells (Abdallah et al. <xref ref-type="bibr" rid="CR1">2008</xref>, <xref ref-type="bibr" rid="CR3">2011</xref>). Also, ESX-5 components are upregulated during phosphate-limiting conditions (Elliot and Tischler <xref ref-type="bibr" rid="CR38">2016</xref>). Even though the specific role of <italic>cyp143a1</italic> remains unclear, its association with the <italic>esx-5</italic> locus may reflect a pivotal contribution to components of the transport channel. Furthermore, ESX-5 transposon insertion mutants in the gene encoding CYP143A1 Mtb were attenuated both in macrophages and in the immunodeficient mouse infection model (Bottai et al. <xref ref-type="bibr" rid="CR14">2012</xref>; Sayes et al. <xref ref-type="bibr" rid="CR111">2012</xref>). The same holds true for MMAR_2666 (<italic>cyp143a1</italic> homolog in <italic>M. marinum</italic>) during infection in RAW, THP-1, or CLC cell lines (Weerdenburg et al. <xref ref-type="bibr" rid="CR125">2015</xref>). These results confirm that CYP143A1 might have a conserved pathogenic role and therefore highlights its potential use as a drug target.</p></sec><sec id="Sec13"><title>Cognate redox partners for Mtb CYPs</title><p id="Par20">The relatively low number of redox partners compared to the number of <italic>CYP</italic> genes in Mtb implies that these redox proteins are promiscuous in mediating electron transfer. However, some CYPs may have evolved with protein binding sites that are specific for (a) certain redox partner(s). Recently, it was shown that the activity of a small selection of Mtb CYPs was supported by several cognate redox partners in vitro (Ortega Ugalde et al. <xref ref-type="bibr" rid="CR90">2018a</xref>). Both Fdx and FdxD supported CYP121A1 catalytic activity with comparable efficiencies whereas FdxD and FdxE supported in vitro reconstitution of cholesterol hydroxylation by Mtb CYP124A1, CYP125A1, and CYP142A1, although with lower efficiency for FdxE. Catalytic efficiencies were equal for the two different FNRs (FdrA and FprA), indicating a flexible CYP/FNR/Fd catalytic system in vivo. Previous studies have shown the ability of the FprA-Fdx redox system to reduce CYP51B1 in vitro (McLean et al. <xref ref-type="bibr" rid="CR79">2006a</xref>). Moreover, the FdrA-Fdx complex was capable of supporting CYP51B1 activity through the same electron transfer system (Zanno et al. <xref ref-type="bibr" rid="CR129">2005</xref>). FdxA was the only ferredoxin unable to transfer electrons to any of the studied CYPs (Ortega Ugalde et al. <xref ref-type="bibr" rid="CR90">2018a</xref>). In addition, FdxC, which has not been successfully expressed yet, is required for optimal growth of Mtb in vitro suggesting a key role in shuttling electrons (Sassetti et al. <xref ref-type="bibr" rid="CR109">2003</xref>; DeJesus et al. <xref ref-type="bibr" rid="CR31">2017</xref>).</p><p id="Par21">Characterization of the electron transfer capabilities of FdxC, FdxB, and FprB, to (all) Mtb CYPs could contribute to understanding the complex biochemistry of the CYP/FNR/Fd network.</p></sec></sec><sec id="Sec14"><title>Mtb CYPs and cognate redox partners expression levels</title><p id="Par22">Mtb encounters a number of physiological stresses that trigger coordinated stress responses orchestrated by protein expression regulation. A summary of transcriptome analyses under different insults focusing on Mtb CYPs and their cognate redox partners is presented in Table <xref rid="Tab2" ref-type="table">2</xref>. Induced expression as part of the Mtb adaptive response could indicate an important role in survival.<table-wrap id="Tab2"><label>Table 2</label><caption xml:lang="en"><p>Expression levels of Mtb CYPs and cognate redox partners</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"><p>Protein</p></th><th rowspan="2"><p>Gene</p></th><th colspan="10"><p>Stress</p></th></tr><tr><th><p>Stationary phase<sup>a</sup></p></th><th><p>Starvation<sup>b</sup></p></th><th><p>pH stress<sup>c</sup></p></th><th><p>NO treatment<sup>d,e</sup></p></th><th><p>CO treatment<sup>f</sup></p></th><th><p>Hypoxia<sup>g,h,i</sup></p></th><th><p>High temperature<sup>j</sup></p></th><th><p>Phagocytosis<sup>k</sup></p></th><th><p>DNA damage<sup>l</sup></p></th><th><p>Salicylate treatment<sup>m</sup></p></th></tr></thead><tbody><tr><td colspan="12"><p>CYPs</p></td></tr><tr><td><p>  CYP121A1</p></td><td><p><italic>Rv2276</italic></p></td><td><p>↓</p></td><td><p>↑</p></td><td><p>–</p></td><td><p>↓</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td></tr><tr><td><p>  CYP123A1</p></td><td><p><italic>Rv0766c</italic></p></td><td><p>–</p></td><td><p>↑</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>↑</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td></tr><tr><td><p>  CYP124A1</p></td><td><p><italic>Rv2266</italic></p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td></tr><tr><td><p>  CYP125A1</p></td><td><p><italic>Rv3545c</italic></p></td><td><p>–</p></td><td><p>↑</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td></tr><tr><td><p>  CYP126A1</p></td><td><p><italic>Rv0778</italic></p></td><td><p>–</p></td><td><p>↑</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td></tr><tr><td><p>  CYP128A1</p></td><td><p><italic>Rv2268c</italic></p></td><td><p>↓</p></td><td><p>↑</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td></tr><tr><td><p>  CYP130A1</p></td><td><p><italic>Rv1256c</italic></p></td><td><p>↓</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td></tr><tr><td><p>  CYP132A1</p></td><td><p><italic>Rv1394c</italic></p></td><td><p>–</p></td><td><p>↑</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td></tr><tr><td><p>  CYP135A1</p></td><td><p><italic>Rv0327c</italic></p></td><td><p>–</p></td><td><p>↑</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td></tr><tr><td><p>  CYP135B1</p></td><td><p><italic>Rv0568</italic></p></td><td><p>–</p></td><td><p>↑</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td></tr><tr><td><p>  CYP136A1</p></td><td><p><italic>Rv3059</italic></p></td><td><p>–</p></td><td><p>↑</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>↑</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td></tr><tr><td><p>  CYP137A1</p></td><td><p><italic>Rv3685c</italic></p></td><td><p>↓</p></td><td><p>↑</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td></tr><tr><td><p>  CYP138A1</p></td><td><p><italic>Rv0136</italic></p></td><td><p>↓</p></td><td><p>↑</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>↑</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td></tr><tr><td><p>  CYP139A1</p></td><td><p><italic>Rv1666c</italic></p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td></tr><tr><td><p>  CYP140A1</p></td><td><p><italic>Rv1880c</italic></p></td><td><p>↓</p></td><td><p>↑</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td></tr><tr><td><p>  CYP141A1</p></td><td><p><italic>Rv3121</italic></p></td><td><p>–</p></td><td><p>↓</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td></tr><tr><td><p>  CYP142A1</p></td><td><p><italic>Rv3518c</italic></p></td><td><p>–</p></td><td><p>↑</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td></tr><tr><td><p>  CYP143A1</p></td><td><p><italic>Rv1785c</italic></p></td><td><p>↓</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td></tr><tr><td><p>  CYP144A1</p></td><td><p><italic>Rv1777</italic></p></td><td><p>↓</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td></tr><tr><td><p>  CYP51B1</p></td><td><p><italic>Rv0764c</italic></p></td><td><p>–</p></td><td><p>↑</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td></tr><tr><td colspan="12"><p>Redox partners</p></td></tr><tr><td><p>  Fdx</p></td><td><p><italic>Rv0763c</italic></p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td></tr><tr><td><p>  FdxA</p></td><td><p><italic>Rv2007c</italic></p></td><td><p>–</p></td><td><p>↓</p></td><td><p>↑</p></td><td><p>↑</p></td><td><p>↑</p></td><td><p>↑</p></td><td><p>↑</p></td><td><p>↑</p></td><td><p>–</p></td><td><p>–</p></td></tr><tr><td><p>  FdxB</p></td><td><p><italic>Rv3554</italic></p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td></tr><tr><td><p>  FdxC</p></td><td><p><italic>Rv1177</italic></p></td><td><p>–</p></td><td><p>↓</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td></tr><tr><td><p>  FdxD</p></td><td><p><italic>Rv3503c</italic></p></td><td><p>–</p></td><td><p>↑</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td></tr><tr><td><p>  FdxE</p></td><td><p><italic>Rv1786</italic></p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td></tr><tr><td><p>  FdrA</p></td><td><p><italic>Rv0688</italic></p></td><td><p>–</p></td><td><p>↑</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td></tr><tr><td><p>  FprA</p></td><td><p><italic>Rv3106</italic></p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>↓</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td></tr><tr><td><p>  FprB</p></td><td><p><italic>Rv0886</italic></p></td><td><p>↑</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>↑</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td><td><p>–</p></td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Hampshire et al. <xref ref-type="bibr" rid="CR52">2004</xref></p><p><sup>b</sup>Betts et al. <xref ref-type="bibr" rid="CR12">2002</xref></p><p><sup>c</sup>Fisher et al. <xref ref-type="bibr" rid="CR42">2002</xref></p><p><sup>d</sup>Voskuil et al. 2003</p><p><sup>e</sup>Namouchi et al. <xref ref-type="bibr" rid="CR87">2016</xref></p><p><sup>f</sup>Shiloh et al. <xref ref-type="bibr" rid="CR116">2008</xref></p><p><sup>g</sup>Sherman et al. <xref ref-type="bibr" rid="CR115">2001</xref></p><p><sup>h</sup>Bacon et al. <xref ref-type="bibr" rid="CR9">2004</xref></p><p><sup>i</sup>Voskuil et al. <xref ref-type="bibr" rid="CR123">2004</xref></p><p><sup>j</sup>Stewart et al. <xref ref-type="bibr" rid="CR118">2002</xref></p><p><sup>k</sup>Schnappinger et al. <xref ref-type="bibr" rid="CR112">2003</xref></p><p><sup>l</sup>Namouchi et al. <xref ref-type="bibr" rid="CR87">2016</xref></p><p><sup>m</sup>Denkin et al. <xref ref-type="bibr" rid="CR32">2005</xref></p></table-wrap-foot></table-wrap></p><sec id="Sec15"><title>Stress response</title><p id="Par23">During latent infection Mtb is thought to survive in granulomas by entering a non-replicating state (Lenaerts et al. <xref ref-type="bibr" rid="CR69">2015</xref>). This condition is the bacterial response to a number of different stimuli, such as lack of nutrients, oxygen depletion, and high concentrations of NO (Betts et al. <xref ref-type="bibr" rid="CR12">2002</xref>; Voskuil et al. <xref ref-type="bibr" rid="CR123">2004</xref>; Bacon et al. <xref ref-type="bibr" rid="CR9">2004</xref>). Transcriptomic studies conducted under conditions that stimulate nutrient depletion have revealed that from the Mtb CYP complement (CYPome), only the expression of <italic>cyp128a1</italic> was upregulated, whereas the remaining CYPs showed a minimal alteration in their expression levels (Betts et al. <xref ref-type="bibr" rid="CR12">2002</xref>). <italic>cyp128a1</italic> induction was also observed upon overproduction of the transcriptional regulators (TRs) WhiB2 and SigF, which are known to be induced as a result of nutrient depletion and thought to be involved in promoting bacterial survival and proliferation during infection in lung granulomas (Fig. <xref rid="Fig2" ref-type="fig">2</xref>) (Sherman et al. <xref ref-type="bibr" rid="CR115">2001</xref>; Bacon et al. <xref ref-type="bibr" rid="CR9">2004</xref>; Voskuil et al. <xref ref-type="bibr" rid="CR123">2004</xref>; Rustad et al. <xref ref-type="bibr" rid="CR107">2014</xref>). Only <italic>cyp136a1</italic> expression was upregulated in response to hypoxic conditions (Sherman et al. <xref ref-type="bibr" rid="CR115">2001</xref>; Bacon et al. <xref ref-type="bibr" rid="CR9">2004</xref>; Voskuil et al. <xref ref-type="bibr" rid="CR123">2004</xref>). Likewise, <italic>cyp136a1</italic> upregulation was also seen by overproduction of WhiB3, a redox-sensitive TR responsive to NO and O<sub>2</sub> as well as upon overproduction of Rv0195, a LuxR transcription factor involved in bacterial virulence in human macrophage-like cells and murine tissues (Fig. <xref rid="Fig2" ref-type="fig">2</xref>) (Fang et al. <xref ref-type="bibr" rid="CR40">2013</xref>; Rustad et al. <xref ref-type="bibr" rid="CR107">2014</xref>). TRs Rv0238 and Rv3058c belong to the TetR family and both regulate efflux pumps and transporters, which are involved in antibiotic resistance and confer tolerance against toxic compounds (Cagliero et al. <xref ref-type="bibr" rid="CR19">2005</xref>; Guazzaroni et al. <xref ref-type="bibr" rid="CR51">2005</xref>; Lin et al. <xref ref-type="bibr" rid="CR71">2005</xref>; Akiba et al. <xref ref-type="bibr" rid="CR6">2006</xref>). Interestingly, overproduction of these two TRs yielded the transcriptional induction of several Mtb CYPs and associated redox partners, such as <italic>cyp128a1</italic>, <italic>cyp136a1</italic>, <italic>cyp143a1</italic>, <italic>cyp136a1</italic>, <italic>Fdx</italic>, and <italic>FdxA</italic>, suggesting an involvement in antibiotic resistance pathways (Fig. <xref rid="Fig2" ref-type="fig">2</xref>) (Rustad et al. <xref ref-type="bibr" rid="CR107">2014</xref>). In contrast, the expression of virtually all Mtb CYPs and redox partners genes was downregulated in the stationary phase following progressive nutrient depletion, which could be explained by the lower transcriptional activity mycobacteria undergo under nutrient starvation (Betts et al. <xref ref-type="bibr" rid="CR12">2002</xref>; Hampshire et al. <xref ref-type="bibr" rid="CR52">2004</xref>). The number of transcripts of FdxA was increased in all conditions known to induce the dormancy regulon (DosR) regulon, especially by reduced O<sub>2</sub> tension, which induces a switch to anaerobic metabolism (Sherman et al. <xref ref-type="bibr" rid="CR115">2001</xref>). In addition, FdxA is upregulated upon activation of the DosR regulon, which is comprises a set of genes that is essential for the pathogen’s ability to persist during lengthy hypoxia and to rapidly recover from non-respiratory dormancy (Fig. <xref rid="Fig2" ref-type="fig">2</xref>) (Rustad et al. <xref ref-type="bibr" rid="CR107">2014</xref>). Only FdxA showed an increased expression after pH stress, phagocytosis, and carbon monoxide (CO) treatment (Table <xref rid="Tab2" ref-type="table">2</xref>). There was also a significant change in its expression level during mycobacterial growth in the immune-competent (BALB/c) and the severe combined immune-deficient (SCID) mice (Fischer et al. <xref ref-type="bibr" rid="CR41">2002</xref>; Voskuil et al., 2003; Talaat et al. <xref ref-type="bibr" rid="CR119">2004</xref>; Shilou et al. 2008; Namouchi et al. <xref ref-type="bibr" rid="CR87">2016</xref>).<fig id="Fig2"><label>Fig. 2</label><caption xml:lang="en"><p>Two-dimensional hierarchical clustering of Mtb CYPs and cognate redox partners expression profiles after transcription factor overexpression. The individual genes are represented on the <italic>x</italic>-axis and the transcription factors are indicated on the <italic>y</italic> axis. Red indicates upregulation whereas green indicates downregulation and white indicates no change relative to time zero control. Data retrieved from Rustad et al. <xref ref-type="bibr" rid="CR107">2014</xref></p></caption><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/253_2019_9697_Fig2_HTML.png" id="MO2"/></fig></p><p id="Par24">Overproduction of KstR, a highly conserved TR that regulates a large set of gene-encoding proteins involved in cholesterol catabolism, resulted in a high induction of <italic>cyp125a1</italic>. In contrast, the other CYPs related to cholesterol metabolism were downregulated (<italic>cyp142a1</italic>) or unchanged in expression (<italic>cyp124a1</italic> and <italic>cyp126a1</italic>) (Fig. <xref rid="Fig2" ref-type="fig">2</xref>) (Rustad et al. <xref ref-type="bibr" rid="CR107">2014</xref>). These results are in line with the reported induction levels of <italic>cyp142a1</italic> in cholesterol-rich growth conditions (Johnston et al. <xref ref-type="bibr" rid="CR61">2010</xref>). These results suggest that even though CYP142A1 is able to catalyze cholesterol oxidation, CYP125A1 is the main monooxygenase involved in this pathway.</p><p id="Par25">Bacteria respond to DNA damage by mounting a coordinated stress response; the so-called SOS response. This response is governed by the DNA repair genes <italic>recA</italic> and its cognate repressor <italic>lexA</italic>. The Mtb CYPs and their cognate electron-transfer partners are not part of the SOS box response. Therefore, it is not surprising that their expression levels remained unchanged upon DNA damage or in response to overproduction of LexA (Table <xref rid="Tab2" ref-type="table">2</xref> and Fig. <xref rid="Fig2" ref-type="fig">2</xref>) (Little <xref ref-type="bibr" rid="CR72">1991</xref>; Davis et al. <xref ref-type="bibr" rid="CR29">2002</xref>; Rustad et al. <xref ref-type="bibr" rid="CR107">2014</xref>; Namouchi et al. <xref ref-type="bibr" rid="CR87">2016</xref>).</p><p id="Par26">A number of TRs mediate the regulation of genes involved in resistance to a diverse array of antibiotics that target different pathways in Mtb. For example, SigB is specifically involved in tolerance to ethambutol and isoniazid, whereas <italic>sigE</italic> null mutant strains are more sensitive to vancomycin, rifampin, streptomycin, gentamicin, isoniazid, and ethambutol (Pisu et al. <xref ref-type="bibr" rid="CR99">2017</xref>). The TRs <italic>Rv0324</italic> and <italic>Rv0880</italic> comprise the tolerance network to the recently marketed antitubercular drug, bedaquiline (Peterson et al. <xref ref-type="bibr" rid="CR98">2016</xref>). On the other hand, WhiB7 shows a more generic spectrum controlling the expression of a plethora of antibiotic resistant genes, such as <italic>tap</italic> (<italic>Rv1258c</italic>) coding for an efflux pump that provides low-level resistance to aminoglycosides and tetracycline or <italic>erm</italic> (<italic>Rv 1988</italic>) homologous to ribosomal methyltransferases and conferring MLS (macrolide, lincosamide, and streptogramin) resistance (De Rossi et al. <xref ref-type="bibr" rid="CR30">2002</xref>; Buriankova et al. <xref ref-type="bibr" rid="CR18">2004</xref>; Burian et al. <xref ref-type="bibr" rid="CR17">2013</xref>). Figure <xref rid="Fig2" ref-type="fig">2</xref> shows that overproduction of SigB and SigE had little effect on expression levels of Mtb CYPs and redox partners. In contrast, <italic>cyp130a1</italic> was slightly upregulated. The same holds true for overproduction of the TRs <italic>Rv0324</italic> and <italic>Rv0880</italic> (both involved in bedaquiline tolerance) which are both result in upregulation of c<italic>yp128a1</italic>, <italic>cyp137a1</italic>, <italic>fdxE</italic>, and <italic>fprB</italic>. Moreover, overproduction of WhiB7 led to increased transcripts of <italic>cyp128a1</italic>, <italic>cyp130a1</italic>, and <italic>fdxA</italic>, suggesting that they are involved in the dealing with the stress consequent to bedaquiline exposure (Fig. <xref rid="Fig2" ref-type="fig">2</xref>) (Rustad et al. <xref ref-type="bibr" rid="CR107">2014</xref>). Interestingly, expression of some of these TRs, such as whiB7, is upregulated by antibiotic treatment, as well as by certain (physiological) stresses including iron starvation and heat shock (Geiman et al. <xref ref-type="bibr" rid="CR46">2006</xref>).</p><p id="Par27">Figure <xref rid="Fig2" ref-type="fig">2</xref> depicts the TRs that are involved in the expression of Mtb CYP and redox partners (Rustad et al. <xref ref-type="bibr" rid="CR107">2014</xref>). Little is known about several TRs depicted in Fig. <xref rid="Fig2" ref-type="fig">2</xref>, such as Rv0081 and Rv0818; however, it is clear that they play a role in CYP biology and are possibly involved in drug tolerance.</p></sec><sec id="Sec16"><title>Antibiotic exposure response</title><p id="Par28">Analysis of the transcriptome response of Mtb to antibiotics is a powerful approach to unveil the pathways contributing to drug resistance and may provide new insights relevant to anti-mycobacterial drug discovery. Recently, Boot et al. studied the stress-fingerprint of Mtb upon exposure to subinhibitory concentrations of first- and second-line TB antibiotics with known targets (Boot et al. <xref ref-type="bibr" rid="CR13">2018</xref>). In Fig. <xref rid="Fig3" ref-type="fig">3</xref>, the transcriptional regulation of Mtb CYPs and redox partners after exposure to these compounds for 4 and 24 h is depicted. It was observed that Mtb mounts a global stress response with similar gene induction/repression to antibiotics, regardless of their cellular target. The antibiotics studied included ciprofloxacin, ethambutol, isoniazid, streptomycin, and rifampicin. Ciprofloxacin inhibits DNA unwinding; ethambutol and isoniazid both target the mycobacterial cell wall; streptomycin inhibits ribosomes; and rifampicin, inhibits RNA polymerase. Furthermore, comparison of the transcriptional response of Mtb at the selected two different time points showed virtually identical overlap, suggesting that Mtb CYPs and associated redox partners play a very specific and robust role upon antibiotic stress (Fig. <xref rid="Fig3" ref-type="fig">3</xref>a, b).<fig id="Fig3"><label>Fig. 3</label><caption xml:lang="en"><p>Two-dimensional hierarchical clustering of Mtb CYPs and cognate redox partners expression profiles in response to first- and second-line antibiotic exposure. <bold>a</bold> After 4-h exposure and <bold>b</bold> after 24-h exposure. The individual genes are represented on the <italic>x</italic>-axis and the antibiotics are indicated on the <italic>y-</italic>axis. Red indicates upregulation whereas green indicates downregulation and white indicates no change relative to time zero control. C = ciprofloxacin, E = ethambutol, I = isoniazid, R = rifampicin, S = streptomycin. Data retrieved from Boot et al. <xref ref-type="bibr" rid="CR13">2018</xref></p></caption><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/253_2019_9697_Fig3_HTML.png" id="MO3"/></fig></p><p id="Par29">Clustering the transcriptional response revealed that <italic>cyp139a1</italic>, <italic>cyp121a1</italic>, <italic>cyp126a1</italic>, and <italic>cyp137a1</italic> together with FdxB, was the most prominently upregulated cluster for all five drugs (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). Interestingly, and as previously mentioned, <italic>cyp139a1</italic> is immediately downstream of three polyketide synthase (<italic>pks</italic>) genes and upstream of <italic>Rv1667c</italic>, a gene encoding an ATP-binding cassette (ABC) superfamily transporter. The expression of the three <italic>pks</italic> is downregulated except for <italic>pks17</italic> and <italic>pks9</italic> genes (<italic>Rv1663</italic> and <italic>Rv1664</italic>, respectively) upon exposure to ciprofloxacin and rifampicin. In contrast, Rv1667c is also induced upon exposure to first-line antibiotics (Zhang et al. <xref ref-type="bibr" rid="CR131">2017</xref>; Boot et al. <xref ref-type="bibr" rid="CR13">2018</xref>). Furthermore, it can also be speculated that increased expression of <italic>cyp139a1</italic> (or one of the other CYPs) contributes to the intrinsic resistance of Mtb to anti-TB agents.</p><p id="Par30"><italic>Cyp143a1</italic> and its tentative associated cognate redox partner, <italic>Rv1786</italic> (FdxE), were upregulated after exposure to these antibiotics (Fig. <xref rid="Fig3" ref-type="fig">3</xref>) (Boot et al. <xref ref-type="bibr" rid="CR13">2018</xref>)<italic>.</italic> Furthermore, the expression of <italic>Rv1790</italic>, encoding PPE27, was also upregulated whereas other genes in the ESX-5 cluster were downregulated or relatively unaffected (Boot et al. <xref ref-type="bibr" rid="CR13">2018</xref>). In addition, FdxA was also induced by exposure to anti-TB compounds, suggesting that this protein is a key player in pathways to resist insults Mtb may encounter in vivo (Fischer et al. <xref ref-type="bibr" rid="CR41">2002</xref>; Voskuil et al. 2003; Shilou et al. 2008; Namouchi et al. <xref ref-type="bibr" rid="CR87">2016</xref>; Boot et al. <xref ref-type="bibr" rid="CR13">2018</xref>). The same holds true for FdxB, after exposure to all four antibiotics (Fig. <xref rid="Fig3" ref-type="fig">3</xref>a, b).</p><p id="Par31">The cluster with the strongest downregulation of transcription consisted of <italic>cyp135a1</italic>, <italic>cyp130a1</italic>, <italic>cyp123a1</italic>, and <italic>cyp125a1</italic> together with the electron transfers FdxC and FdxD. A plausible explanation could be that these proteins are constitutively highly expressed (Ricagno et al. <xref ref-type="bibr" rid="CR104">2007</xref>). CYP125A1 was shown to be essential for Mtb growth in cholesterol. Its downregulation under antibiotic exposure is consistent with the capability of the bacteria to distinguish different stresses, triggering specific transcriptomic responses (Griffin et al. <xref ref-type="bibr" rid="CR49">2011</xref>).</p><p id="Par32">The transcriptional response to bedaquiline was opposite to the results presented in Fig. <xref rid="Fig3" ref-type="fig">3</xref> for the classical anti-TB drugs (Peterson et al. <xref ref-type="bibr" rid="CR98">2016</xref>). <italic>Cyp121a1</italic>, <italic>cyp126a1</italic>, <italic>cyp137a1</italic>, and <italic>cyp141a1</italic> were significantly downregulated, whereas <italic>cyp125a1</italic> and <italic>FdxE</italic> were clearly upregulated. This alteration in transcriptome response likely reflects the different mechanism of action of bedaquiline, namely inhibition of the F<sub>1</sub>F<sub>0</sub>-ATP synthase of Mtb, preventing any specific response to be mounted. In addition, it could be the result of bedaquiline-induced decreased protein synthesis due to downregulation of ribosomal subunits (Koul et al. <xref ref-type="bibr" rid="CR64">2014</xref>).</p><p id="Par33">Due to the absence of correlation between the transcriptional response of the CYPome after overproduction of several TRs (Fig. <xref rid="Fig2" ref-type="fig">2</xref>) and after exposure to anti-TB drugs (Fig. <xref rid="Fig3" ref-type="fig">3</xref>), it is not possible to identify TRs which are activated upon antibiotic exposure.</p></sec></sec><sec id="Sec17"><title>Targeting Mtb CYPs: state of art</title><p id="Par34">Insights into the essentiality of Mtb CYPs and their natural redox partners and the transcriptomic response to external insults are useful to evaluate their potential as therapeutic targets to combat TB. In particular, CYP121A1 and CYP125A1/CYP142A1 are considered promising drug-targets, because several azole-drugs, such as econazole, clotrimazole, and miconazole, bind with high affinities to these Mtb CYPs. Moreover these compounds have been shown to be potent antimycobacterials in vitro, being effective even against persistent and multidrug-resistant strains of Mtb (McLean et al. <xref ref-type="bibr" rid="CR77">2002b</xref>; Ahmad et al. <xref ref-type="bibr" rid="CR4">2006a</xref>, <xref ref-type="bibr" rid="CR5">b</xref>; McLean and Munro <xref ref-type="bibr" rid="CR75">2008</xref>). In addition, the development of CYP inhibitors relies mostly on high-throughput compound screens (HTS) and fragment-based approaches which provide foundations for a more rational design of selective Mtb CYP inhibitors (Fig. <xref rid="Fig4" ref-type="fig">4</xref>a, b). HTS to find potent and highly selective inhibitors of CYP126A1 and CYP130A1 has been performed (Podust et al. <xref ref-type="bibr" rid="CR102">2009</xref>; Hudson et al. <xref ref-type="bibr" rid="CR56">2014</xref>). In addition, these studies aimed to identify substrates for the orphan CYP126A1 and CYP130A1, which would help to define their physiological roles. This HTS screening on Mtb CYP130A1 identified some inhibitors, belonging to the heterocyclic arylamines which have been shown to cause toxicity issues, deterring their exploitation as antibiotics (Fig. <xref rid="Fig4" ref-type="fig">4</xref>c) (Podust et al. <xref ref-type="bibr" rid="CR102">2009</xref>; Kim and Guengerich <xref ref-type="bibr" rid="CR63">2005</xref>). Furthermore, fragment-based approaches have been applied to CYP121A1 (Hudson et al. <xref ref-type="bibr" rid="CR54">2012</xref>; Hudson et al. <xref ref-type="bibr" rid="CR55">2013</xref>; Kavanagh et al. <xref ref-type="bibr" rid="CR62">2016</xref>). These studies have led to the identification of high affinity type-II binding compounds, with <italic>K</italic><sub><italic>D</italic></sub> values as low as 15 nM, high Mtb CYP selectivity and low off-target interaction with human CYPs (Fig. <xref rid="Fig4" ref-type="fig">4</xref>d) (Kavanagh et al. <xref ref-type="bibr" rid="CR62">2016</xref>). However, no significant inhibition of bacterial growth was detected for any of the lead compounds (MIC<sub>90</sub> ≥ 50 μM) probably due to low membrane permeability and/or increased expression of efflux transporters (Kavanagh et al. <xref ref-type="bibr" rid="CR62">2016</xref>).<fig id="Fig4"><label>Fig. 4</label><caption xml:lang="en"><p>Schematic representation of the strategies for Mtb CYP inhibitors identification. <bold>a</bold> Fragment-based (FB), where fragments are screened against the target of interest, leading to identification of hits, which are linked/grown/merged and finally optimized to generate lead compounds. <bold>b</bold> HTS, where compounds are screened against the target of interest, leading to identification of hit compounds with often lack of optimal interactions with the target. <bold>c</bold> HTS identified high-affinity inhibitor-like binding heterocyclic arylamines for CYP130A1 (Podust et al. <xref ref-type="bibr" rid="CR102">2009</xref>). <bold>d</bold> FB identified high-affinity inhibitor-like compounds for CYP121A1 (Hudson et al. <xref ref-type="bibr" rid="CR54">2012</xref>, <xref ref-type="bibr" rid="CR55">2013</xref>; Kavanagh et al. <xref ref-type="bibr" rid="CR62">2016</xref>). <bold>e</bold> HTS identified and specifically synthetized inhibitors for CYP125A1/CYP142A1 (Chen et al. <xref ref-type="bibr" rid="CR23">2009</xref>; Ouellet et al. <xref ref-type="bibr" rid="CR95">2011</xref>; Brengel et al. <xref ref-type="bibr" rid="CR15">2016</xref>; Frank et al. <xref ref-type="bibr" rid="CR44">2016</xref>)</p></caption><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/253_2019_9697_Fig4_HTML.png" id="MO4"/></fig></p><p id="Par35">The CYP inhibitor LP10, initially discovered to block CYP51 from <italic>Trypanosoma cruzi</italic>, showed moderate inhibition of CYP125A1 (Fig. <xref rid="Fig4" ref-type="fig">4</xref>e) (Chen et al. <xref ref-type="bibr" rid="CR23">2009</xref>; Ouellet et al. <xref ref-type="bibr" rid="CR95">2011</xref>). Moreover, screening assays have identified a compound that can inhibit CYP125A1/CYP142A1 (C128), and has a <italic>K</italic><sub><italic>D</italic></sub> equal to 85 nM (Fig. <xref rid="Fig4" ref-type="fig">4</xref>e) (Brengel et al. <xref ref-type="bibr" rid="CR15">2016</xref>). Furthermore, two terminally truncated cholesterol analogs with fluorinated side chains were shown to inhibit growth of Mtb (Fig. <xref rid="Fig4" ref-type="fig">4</xref>e) (Frank et al. <xref ref-type="bibr" rid="CR44">2016</xref>). However, direct inhibition of CYP125A1 and/or CYP142A1 could not be confirmed and the observed growth inhibition was independent of the presence of CYP125A1 (Frank et al. <xref ref-type="bibr" rid="CR44">2016</xref>).</p></sec></sec><sec id="Sec18"><title>Concluding remarks</title><p id="Par36">New anti-TB drugs are needed to fight resistance and combination therapies provide the most effective treatment of tuberculosis. As such, Mtb CYPs could provide one of the drug targets, as they conduct very specific roles for the pathogen. In addition, their uniqueness to Mtb highlights their attractiveness as therapeutic targets avoiding off-target toxicity. The transcriptional response upon external insults mimicking in vivo situation and drug exposure showed that Mtb CYPs and cognate redox partners might be involved in the adaptation of the pathogen to antibiotics. Further studies will focus on the further biochemical characterization of (orphan) CYPs and redox partners as well as defining the contribution of individual genes by using knockout or knockdown mutants to shed light on their physiological role and their plausible involvement in resistance to antibiotics.</p></sec></body><back><sec><title>Funding</title><p>This study was funded by The Netherlands Organization for Scientific Research NWO-AIMMS STAR Graduate Program (grant no. 022.005.031 to S. Ortega Ugalde).</p></sec><sec sec-type="ethics-statement"><title>Compliance with ethical standards</title><sec id="FPar1" sec-type="COI-statement"><title>Conflict of interest</title><p id="Par37">The authors declare that they have no conflict of interest.</p></sec><sec id="FPar2"><title>Ethical statement</title><p id="Par38">This article does not contain any studies with human participants or animals performed by any of the authors.</p></sec></sec><ref-list id="Bib1"><title>References</title><ref-list><ref id="CR1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdallah</surname><given-names>AM</given-names></name><name><surname>Savage</surname><given-names>ND</given-names></name><name><surname>van Zon</surname><given-names>M</given-names></name><name><surname>Wilson</surname><given-names>L</given-names></name><name><surname>Vandenbroucke-Grauls</surname><given-names>CM</given-names></name><name><surname>van der Wel</surname><given-names>NN</given-names></name><name><surname>Ottenhoff</surname><given-names>TH</given-names></name><name><surname>Bitter</surname><given-names>W</given-names></name></person-group><article-title xml:lang="en">The ESX-5 secretion system of <italic>Mycobacterium marinum</italic> modulates the macrophage response</article-title><source>J Immunol</source><year>2008</year><volume>181</volume><fpage>7166</fpage><lpage>7175</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.181.10.7166</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXhtlaisrvF</pub-id><pub-id pub-id-type="pmid">18981138</pub-id></mixed-citation></ref><ref id="CR2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdallah</surname><given-names>AM</given-names></name><name><surname>Verboom</surname><given-names>T</given-names></name><name><surname>Weerdenburg</surname><given-names>EM</given-names></name><name><surname>Gey van Pittius</surname><given-names>NC</given-names></name><name><surname>Mahasha</surname><given-names>PW</given-names></name><name><surname>Jiménez</surname><given-names>C</given-names></name><name><surname>Parra</surname><given-names>M</given-names></name><name><surname>Cadieux</surname><given-names>N</given-names></name><name><surname>Brennan</surname><given-names>MJ</given-names></name><name><surname>Appelmelk</surname><given-names>BJ</given-names></name><name><surname>Bitter</surname><given-names>W</given-names></name></person-group><article-title xml:lang="en">PPE and PE-PGRS proteins of <italic>Mycobacterium marinum</italic> are transported via the type VII secretion system ESX-5</article-title><source>Mol Microbiol</source><year>2009</year><volume>73</volume><fpage>329</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2009.06783.x</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXhtVWksbbJ</pub-id><pub-id pub-id-type="pmid">19602152</pub-id></mixed-citation></ref><ref id="CR3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdallah</surname><given-names>AM</given-names></name><name><surname>Bestebroer</surname><given-names>J</given-names></name><name><surname>Savage</surname><given-names>ND</given-names></name><name><surname>de Punder</surname><given-names>K</given-names></name><name><surname>van Zon</surname><given-names>M</given-names></name><name><surname>Wilson</surname><given-names>L</given-names></name><name><surname>Korbee</surname><given-names>CJ</given-names></name><name><surname>van der Sar</surname><given-names>AM</given-names></name><name><surname>Ottenhoff</surname><given-names>TH</given-names></name><name><surname>van der Wel</surname><given-names>NN</given-names></name><name><surname>Bitter</surname><given-names>W</given-names></name><name><surname>Peters</surname><given-names>PJ</given-names></name></person-group><article-title xml:lang="en">Mycobacterial secretion systems ESX-1 and ESX-5 play distinct roles in host cell death and inflammasome activation</article-title><source>J Immunol</source><year>2011</year><volume>187</volume><fpage>4744</fpage><lpage>4753</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1101457</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXhtlChtr%2FJ</pub-id><pub-id pub-id-type="pmid">21957139</pub-id></mixed-citation></ref><ref id="CR4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>Z</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Khuller</surname><given-names>GK</given-names></name></person-group><article-title xml:lang="en">Azole antifungals as novel chemotherapeutic agents against murine tuberculosis</article-title><source>FEMS Microbiol Lett</source><year>2006</year><volume>261</volume><fpage>181</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6968.2006.00350.x</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28XovFyhsL8%3D</pub-id><pub-id pub-id-type="pmid">16907718</pub-id></mixed-citation></ref><ref id="CR5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>Z</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Khuller</surname><given-names>GK</given-names></name><name><surname>Singh</surname><given-names>P</given-names></name><name><surname>Faujdar</surname><given-names>J</given-names></name><name><surname>Katoch</surname><given-names>VM</given-names></name></person-group><article-title xml:lang="en">Antimycobacterial activity of econazole against multidrug-resistant strains of <italic>Mycobacterium tuberculosis</italic></article-title><source>Int J Antimicrob Agents</source><year>2006</year><volume>28</volume><issue>6</issue><fpage>543</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2006.07.028</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28Xht1eqsL%2FM</pub-id><pub-id pub-id-type="pmid">17101262</pub-id></mixed-citation></ref><ref id="CR6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akiba</surname><given-names>M</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Barton</surname><given-names>YW</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name></person-group><article-title xml:lang="en">Interaction of CmeABC and CmeDEF in conferring antimicrobial resistance and maintaining cell viability in <italic>Campylobacter jejuni</italic></article-title><source>J Antimicrob Chemother</source><year>2006</year><volume>57</volume><fpage>52</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1093/jac/dki419</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28XisF2jsA%3D%3D</pub-id><pub-id pub-id-type="pmid">16303882</pub-id></mixed-citation></ref><ref id="CR7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aoyama</surname><given-names>Y</given-names></name><name><surname>Horiuchi</surname><given-names>T</given-names></name><name><surname>Gotoh</surname><given-names>O</given-names></name><name><surname>Noshiro</surname><given-names>M</given-names></name><name><surname>Yoshida</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">CYP51-like gene of <italic>Mycobacterium tuberculosis</italic> actually encodes a P450 similar to eukaryotic CYP51</article-title><source>J Biochem</source><year>1998</year><volume>124</volume><issue>4</issue><fpage>694</fpage><lpage>696</lpage><pub-id pub-id-type="doi">10.1093/oxfordjournals.jbchem.a022167</pub-id><pub-id pub-id-type="coi">1:CAS:528:DyaK1cXmvF2mu7c%3D</pub-id><pub-id pub-id-type="pmid">9756611</pub-id></mixed-citation></ref><ref id="CR8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ates</surname><given-names>LS</given-names></name><name><surname>Ummels</surname><given-names>R</given-names></name><name><surname>Commandeur</surname><given-names>S</given-names></name><name><surname>van de Weerd</surname><given-names>R</given-names></name><name><surname>Sparrius</surname><given-names>M</given-names></name><name><surname>Weerdenburg</surname><given-names>E</given-names></name><name><surname>Alber</surname><given-names>M</given-names></name><name><surname>Kalscheuer</surname><given-names>R</given-names></name><name><surname>Piersma</surname><given-names>SR</given-names></name><name><surname>Abdallah</surname><given-names>AM</given-names></name><name><surname>Abd El Ghany</surname><given-names>M</given-names></name><name><surname>Abdel-Haleem</surname><given-names>AM</given-names></name><name><surname>Pain</surname><given-names>A</given-names></name><name><surname>Jiménez</surname><given-names>CR</given-names></name><name><surname>Bitter</surname><given-names>W</given-names></name><name><surname>Houben</surname><given-names>EN</given-names></name></person-group><article-title xml:lang="en">Essential role of the ESX-5 secretion system in outer membrane permeability of pathogenic mycobacteria</article-title><source>PLoS Genet</source><year>2015</year><volume>11</volume><pub-id pub-id-type="doi">10.1371/journal.pgen.1005190</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XlvVCmsbw%3D</pub-id><pub-id pub-id-type="pmid">25938982</pub-id><pub-id pub-id-type="pmcid">4418733</pub-id></mixed-citation></ref><ref id="CR9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bacon</surname><given-names>J</given-names></name><name><surname>James</surname><given-names>BW</given-names></name><name><surname>Wernisch</surname><given-names>L</given-names></name><name><surname>Williams</surname><given-names>A</given-names></name><name><surname>Morley</surname><given-names>KA</given-names></name><name><surname>Hatch</surname><given-names>GJ</given-names></name><name><surname>Mangan</surname><given-names>JA</given-names></name><name><surname>Hinds</surname><given-names>J</given-names></name><name><surname>Stoker</surname><given-names>NG</given-names></name><name><surname>Butcher</surname><given-names>PD</given-names></name><name><surname>Marsh</surname><given-names>PD</given-names></name></person-group><article-title xml:lang="en">The influence of reduced oxygen availability on pathogenicity and gene expression in <italic>Mycobacterium tuberculosis</italic></article-title><source>Tuberculosis</source><year>2004</year><volume>84</volume><issue>3–4</issue><fpage>205</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1016/j.tube.2003.12.011</pub-id><pub-id pub-id-type="pmid">15207490</pub-id></mixed-citation></ref><ref id="CR10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belin</surname><given-names>P</given-names></name><name><surname>Le Du</surname><given-names>MH</given-names></name><name><surname>Fielding</surname><given-names>A</given-names></name><name><surname>Lequin</surname><given-names>O</given-names></name><name><surname>Jacquet</surname><given-names>M</given-names></name><name><surname>Charbonnier</surname><given-names>JB</given-names></name><name><surname>Lecoq</surname><given-names>A</given-names></name><name><surname>Thai</surname><given-names>R</given-names></name><name><surname>Courçon</surname><given-names>M</given-names></name><name><surname>Masson</surname><given-names>C</given-names></name><name><surname>Dugave</surname><given-names>C</given-names></name><name><surname>Genet</surname><given-names>R</given-names></name><name><surname>Perdonet</surname><given-names>JL</given-names></name><name><surname>Gondry</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Identification and structural basis of the reaction catalyzed by CYP121, an essential cytochrome P450 in <italic>Mycobacterium tuberculosis</italic></article-title><source>Proc Natl Acad Sci U S A</source><year>2009</year><volume>106</volume><issue>18</issue><fpage>7426</fpage><lpage>7431</lpage><pub-id pub-id-type="doi">10.1073/pnas.0812191106</pub-id><pub-id pub-id-type="pmid">19416919</pub-id><pub-id pub-id-type="pmcid">2678619</pub-id></mixed-citation></ref><ref id="CR11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellamine</surname><given-names>A</given-names></name><name><surname>Mangla</surname><given-names>AT</given-names></name><name><surname>Nes</surname><given-names>WD</given-names></name><name><surname>Waterman</surname><given-names>MR</given-names></name></person-group><article-title xml:lang="en">Characterization and catalytic properties of the sterol 14α-demethylase from <italic>Mycobacterium tuberculosis</italic></article-title><source>Proc Natl Acad Sci U S A</source><year>1999</year><volume>96</volume><issue>16</issue><fpage>8937</fpage><lpage>8942</lpage><pub-id pub-id-type="doi">10.1073/pnas.96.16.8937</pub-id><pub-id pub-id-type="coi">1:CAS:528:DyaK1MXltVeqsbg%3D</pub-id><pub-id pub-id-type="pmid">10430874</pub-id><pub-id pub-id-type="pmcid">17711</pub-id></mixed-citation></ref><ref id="CR12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betts</surname><given-names>JC</given-names></name><name><surname>Lukey</surname><given-names>PT</given-names></name><name><surname>Robb</surname><given-names>LC</given-names></name><name><surname>McAdam</surname><given-names>RA</given-names></name><name><surname>Duncan</surname><given-names>K</given-names></name></person-group><article-title xml:lang="en">Evaluation of a nutrient starvation model of <italic>Mycobacterium tuberculosis</italic> persistence by gene and protein expression profiling</article-title><source>Mol Microbiol</source><year>2002</year><volume>43</volume><issue>3</issue><fpage>717</fpage><lpage>731</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2958.2002.02779.x</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD38XitlWhurk%3D</pub-id><pub-id pub-id-type="pmid">11929527</pub-id></mixed-citation></ref><ref id="CR13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boot</surname><given-names>M</given-names></name><name><surname>Commandeur</surname><given-names>S</given-names></name><name><surname>Subudhi</surname><given-names>AK</given-names></name><name><surname>Bahira</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>TC</given-names><suffix>2nd</suffix></name><name><surname>Abdallah</surname><given-names>AM</given-names></name><name><surname>van Gemert</surname><given-names>M</given-names></name><name><surname>Lelièvre</surname><given-names>J</given-names></name><name><surname>Ballell</surname><given-names>L</given-names></name><name><surname>Aldridge</surname><given-names>BB</given-names></name><name><surname>Pain</surname><given-names>A</given-names></name><name><surname>Speer</surname><given-names>A</given-names></name><name><surname>Bitter</surname><given-names>W</given-names></name></person-group><article-title xml:lang="en">Accelerating early antituberculosis drug discovery by creating mycobacterial indicator strains that predict mode of action</article-title><source>Antimicrob Agents Chemother</source><year>2018</year><volume>62</volume><issue>7</issue><fpage>e00083</fpage><lpage>e00018</lpage><pub-id pub-id-type="doi">10.1128/AAC.00083-18</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXhvFOltbrL</pub-id><pub-id pub-id-type="pmid">29661879</pub-id><pub-id pub-id-type="pmcid">6021670</pub-id></mixed-citation></ref><ref id="CR14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bottai</surname><given-names>D</given-names></name><name><surname>Di Luca</surname><given-names>M</given-names></name><name><surname>Majlessi</surname><given-names>L</given-names></name><name><surname>Frigui</surname><given-names>W</given-names></name><name><surname>Simeone</surname><given-names>R</given-names></name><name><surname>Sayes</surname><given-names>F</given-names></name><name><surname>Bitter</surname><given-names>W</given-names></name><name><surname>Brennan</surname><given-names>MJ</given-names></name><name><surname>Leclerc</surname><given-names>C</given-names></name><name><surname>Batoni</surname><given-names>G</given-names></name><name><surname>Campa</surname><given-names>M</given-names></name><name><surname>Brosch</surname><given-names>R</given-names></name><name><surname>Esin</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">Disruption of the ESX-5 system of <italic>Mycobacterium tuberculosis</italic> causes loss of PPE protein secretion, reduction of cell wall integrity and strong attenuation</article-title><source>Mol Microbiol</source><year>2012</year><volume>83</volume><fpage>1195</fpage><lpage>1209</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2012.08001.x</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XltFSitbk%3D</pub-id><pub-id pub-id-type="pmid">22340629</pub-id></mixed-citation></ref><ref id="CR15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brengel</surname><given-names>C</given-names></name><name><surname>Thomann</surname><given-names>A</given-names></name><name><surname>Schifrin</surname><given-names>A</given-names></name><name><surname>Eberhard</surname><given-names>J</given-names></name><name><surname>Hartmann</surname><given-names>RW</given-names></name></person-group><article-title xml:lang="en">Discovery and biophysical evaluation of first low Nanomolar hits targeting CYP125 of <italic>Mycobacterium tuberculosis</italic></article-title><source>ChemMedChem</source><year>2016</year><volume>11</volume><issue>21</issue><fpage>2385</fpage><lpage>2391</lpage><pub-id pub-id-type="doi">10.1002/cmdc.201600361</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XhsFKru7bN</pub-id><pub-id pub-id-type="pmid">27677638</pub-id></mixed-citation></ref><ref id="CR16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burian</surname><given-names>J</given-names></name><name><surname>Ramón-García</surname><given-names>S</given-names></name><name><surname>Howes</surname><given-names>CG</given-names></name><name><surname>Thompson</surname><given-names>CJ</given-names></name></person-group><article-title xml:lang="en">WhiB7, a transcriptional activator that coordinates physiology with intrinsic drug resistance in <italic>Mycobacterium tuberculosis</italic></article-title><source>Expert Rev Anti-Infect Ther</source><year>2012</year><volume>10</volume><issue>9</issue><fpage>1037</fpage><lpage>1047</lpage><pub-id pub-id-type="doi">10.1586/eri.12.90</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XhsFOqsbbM</pub-id><pub-id pub-id-type="pmid">23106278</pub-id></mixed-citation></ref><ref id="CR17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burian</surname><given-names>J</given-names></name><name><surname>Yim</surname><given-names>G</given-names></name><name><surname>Hsing</surname><given-names>M</given-names></name><name><surname>Axerio-Cilies</surname><given-names>P</given-names></name><name><surname>Cherkasov</surname><given-names>A</given-names></name><name><surname>Spiegelman</surname><given-names>GB</given-names></name><name><surname>Thompson</surname><given-names>CJ</given-names></name></person-group><article-title xml:lang="en">The mycobacterial antibiotic resistance determinant WhiB7 acts asa transcriptional activator by binding the primary sigma factor SigA (RpoV)</article-title><source>Nucleic Acids Res</source><year>2013</year><volume>41</volume><issue>22</issue><fpage>10062</fpage><lpage>10076</lpage><pub-id pub-id-type="doi">10.1093/nar/gkt751</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXhvV2lsbrL</pub-id><pub-id pub-id-type="pmid">23990327</pub-id><pub-id pub-id-type="pmcid">3905903</pub-id></mixed-citation></ref><ref id="CR18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buriankova</surname><given-names>K</given-names></name><name><surname>Doucet-Populaire</surname><given-names>F</given-names></name><name><surname>Dorson</surname><given-names>O</given-names></name><name><surname>Gondran</surname><given-names>A</given-names></name><name><surname>Ghnassia</surname><given-names>JC</given-names></name><name><surname>Weiser</surname><given-names>J</given-names></name><name><surname>Pernodet</surname><given-names>JL</given-names></name></person-group><article-title xml:lang="en">Molecular basis of intrinsic macrolide resistance in the <italic>Mycobacterium tuberculosis</italic> complex</article-title><source>Antimicrob Agents Chemother</source><year>2004</year><volume>48</volume><fpage>143</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1128/AAC.48.1.143-150.2004</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2cXlsVKrtQ%3D%3D</pub-id><pub-id pub-id-type="pmid">14693532</pub-id><pub-id pub-id-type="pmcid">310192</pub-id></mixed-citation></ref><ref id="CR19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cagliero</surname><given-names>C</given-names></name><name><surname>Mouline</surname><given-names>C</given-names></name><name><surname>Payot</surname><given-names>S</given-names></name><name><surname>Cloeckaert</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Involvement of the CmeABC efflux pump in the macrolide resistance of <italic>Campylobacter coli</italic></article-title><source>J Antimicrob Chemother</source><year>2005</year><volume>56</volume><fpage>948</fpage><lpage>950</lpage><pub-id pub-id-type="doi">10.1093/jac/dki292</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXhtFCjtLjN</pub-id><pub-id pub-id-type="pmid">16157618</pub-id></mixed-citation></ref><ref id="CR20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capyk</surname><given-names>JK</given-names></name><name><surname>Kalscheuer</surname><given-names>R</given-names></name><name><surname>Stewart</surname><given-names>GR</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Kwon</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>R</given-names></name><name><surname>Okamoto</surname><given-names>S</given-names></name><name><surname>Jacobs</surname><given-names>WR</given-names><suffix>Jr</suffix></name><name><surname>Eltis</surname><given-names>LD</given-names></name><name><surname>Mohn</surname><given-names>WW</given-names></name></person-group><article-title xml:lang="en">Mycobacterial cytochrome p450 125 (cyp125) catalyzes the terminal hydroxylation of c27 steroids</article-title><source>J Biol Chem</source><year>2009</year><volume>284</volume><issue>51</issue><fpage>35534</fpage><lpage>35542</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.072132</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXhsFCqurnL</pub-id><pub-id pub-id-type="pmid">19846551</pub-id><pub-id pub-id-type="pmcid">2790983</pub-id></mixed-citation></ref><ref id="CR21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>JC</given-names></name><name><surname>Harik</surname><given-names>NS</given-names></name><name><surname>Liao</surname><given-names>RP</given-names></name><name><surname>Sherman</surname><given-names>DR</given-names></name></person-group><article-title xml:lang="en">Identification of mycobacterial genes that alter growth and pathology in macrophages and in mice</article-title><source>J Infect Dis</source><year>2007</year><volume>196</volume><issue>5</issue><fpage>788</fpage><lpage>795</lpage><pub-id pub-id-type="doi">10.1086/520089</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXhtVCqs7jK</pub-id><pub-id pub-id-type="pmid">17674323</pub-id></mixed-citation></ref><ref id="CR22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>JC</given-names></name><name><surname>Miner</surname><given-names>MD</given-names></name><name><surname>Pandey</surname><given-names>AK</given-names></name><name><surname>Gill</surname><given-names>WP</given-names></name><name><surname>Harik</surname><given-names>NS</given-names></name><name><surname>Sassetti</surname><given-names>CM</given-names></name><name><surname>Sherman</surname><given-names>DR</given-names></name></person-group><article-title xml:lang="en">Igr genes and <italic>Mycobacterium tuberculosis</italic> cholesterol metabolism</article-title><source>J Bacteriol</source><year>2009</year><volume>191</volume><issue>16</issue><fpage>5232</fpage><lpage>5239</lpage><pub-id pub-id-type="doi">10.1128/JB.00452-09</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXhtVSis7zI</pub-id><pub-id pub-id-type="pmid">19542286</pub-id><pub-id pub-id-type="pmcid">2725594</pub-id></mixed-citation></ref><ref id="CR23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>CK</given-names></name><name><surname>Doyle</surname><given-names>PS</given-names></name><name><surname>Yermalitskaya</surname><given-names>LV</given-names></name><name><surname>Mackey</surname><given-names>ZB</given-names></name><name><surname>Ang</surname><given-names>KK</given-names></name><name><surname>McKerrow</surname><given-names>JH</given-names></name><name><surname>Podust</surname><given-names>LM</given-names></name></person-group><article-title xml:lang="en"><italic>Trypanosoma cruzi</italic> CYP51 inhibitor derived from a <italic>Mycobacterium tuberculosis</italic> screen hit</article-title><source>PLoS Negl Trop Dis</source><year>2009</year><volume>3</volume><issue>2</issue><fpage>e372</fpage><pub-id pub-id-type="doi">10.1371/journal.pntd.0000372</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXltVGqt7c%3D</pub-id><pub-id pub-id-type="pmid">19190730</pub-id><pub-id pub-id-type="pmcid">2629123</pub-id></mixed-citation></ref><ref id="CR24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>CK</given-names></name><name><surname>Leung</surname><given-names>SSF</given-names></name><name><surname>Guilbert</surname><given-names>C</given-names></name><name><surname>Jacobson</surname><given-names>MP</given-names></name><name><surname>Mckerrow</surname><given-names>JH</given-names></name><name><surname>Podust</surname><given-names>LM</given-names></name></person-group><article-title xml:lang="en">Structural characterization of CYP51 from <italic>Trypanosoma cruzi</italic> and <italic>Trypanosoma brucei</italic> bound to the antifungal drugs posaconazole and fluconazole</article-title><source>PLoS Negl Trop Dis</source><year>2010</year><volume>4</volume><pub-id pub-id-type="doi">10.1371/journal.pntd.0000651</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXkvFyntr4%3D</pub-id><pub-id pub-id-type="pmid">20386598</pub-id><pub-id pub-id-type="pmcid">2850312</pub-id></mixed-citation></ref><ref id="CR25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiaradia</surname><given-names>L</given-names></name><name><surname>Lefebvre</surname><given-names>C</given-names></name><name><surname>Parra</surname><given-names>J</given-names></name><name><surname>Marcoux</surname><given-names>J</given-names></name><name><surname>Burlet-Schiltz</surname><given-names>O</given-names></name><name><surname>Etienne</surname><given-names>G</given-names></name><name><surname>Tropis</surname><given-names>M</given-names></name><name><surname>Daffé</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Dissecting the mycobacterial cell envelope and defining the composition of the native mycomembrane</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><issue>1</issue><fpage>12807</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-12718-4</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXhsVertLnI</pub-id><pub-id pub-id-type="pmid">28993692</pub-id><pub-id pub-id-type="pmcid">5634507</pub-id></mixed-citation></ref><ref id="CR26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Child</surname><given-names>SA</given-names></name><name><surname>Bradley</surname><given-names>JM</given-names></name><name><surname>Pukala</surname><given-names>TL</given-names></name><name><surname>Svistunenko</surname><given-names>DA</given-names></name><name><surname>Le Brun</surname><given-names>NE</given-names></name><name><surname>Bell</surname><given-names>SG</given-names></name></person-group><article-title xml:lang="en">Electron transfer ferredoxins with unusual cluster binding motifs support secondary metabolism in many bacteria</article-title><source>Chem Sci</source><year>2018</year><volume>9</volume><issue>41</issue><fpage>7948</fpage><lpage>7957</lpage><pub-id pub-id-type="doi">10.1039/C8SC01286E</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXhsFOjsLzE</pub-id><pub-id pub-id-type="pmid">30542550</pub-id><pub-id pub-id-type="pmcid">6237146</pub-id></mixed-citation></ref><ref id="CR27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cole</surname><given-names>ST</given-names></name><name><surname>Brosch</surname><given-names>R</given-names></name><name><surname>Parkhill</surname><given-names>J</given-names></name><name><surname>Garnier</surname><given-names>T</given-names></name><name><surname>Churcher</surname><given-names>C</given-names></name><name><surname>Harris</surname><given-names>D</given-names></name><name><surname>Gordon</surname><given-names>SV</given-names></name><name><surname>Eiglmeier</surname><given-names>K</given-names></name><name><surname>Gas</surname><given-names>S</given-names></name><name><surname>Barry</surname><given-names>CE</given-names><suffix>3rd</suffix></name><name><surname>Tekaia</surname><given-names>F</given-names></name><name><surname>Badcock</surname><given-names>K</given-names></name><name><surname>Basham</surname><given-names>D</given-names></name><name><surname>Brown</surname><given-names>D</given-names></name><name><surname>Chillingworth</surname><given-names>T</given-names></name><name><surname>Connor</surname><given-names>R</given-names></name><name><surname>Davies</surname><given-names>R</given-names></name><name><surname>Dev-Lin</surname><given-names>K</given-names></name><name><surname>Feltwell</surname><given-names>T</given-names></name><name><surname>Gentles</surname><given-names>S</given-names></name><name><surname>Hamlin</surname><given-names>N</given-names></name><name><surname>Holroyd</surname><given-names>S</given-names></name><name><surname>Hornsby</surname><given-names>T</given-names></name><name><surname>Jagels</surname><given-names>K</given-names></name><name><surname>Krogh</surname><given-names>A</given-names></name><name><surname>McLean</surname><given-names>J</given-names></name><name><surname>Moule</surname><given-names>S</given-names></name><name><surname>Murphy</surname><given-names>L</given-names></name><name><surname>Oliver</surname><given-names>K</given-names></name><name><surname>Osborne</surname><given-names>J</given-names></name><name><surname>Quail</surname><given-names>MA</given-names></name><name><surname>Rajandream</surname><given-names>MA</given-names></name><name><surname>Rogers</surname><given-names>J</given-names></name><name><surname>Rutter</surname><given-names>S</given-names></name><name><surname>Seeger</surname><given-names>K</given-names></name><name><surname>Skelton</surname><given-names>J</given-names></name><name><surname>Squares</surname><given-names>R</given-names></name><name><surname>Squares</surname><given-names>S</given-names></name><name><surname>Sulston</surname><given-names>JE</given-names></name><name><surname>Taylor</surname><given-names>K</given-names></name><name><surname>Whitehead</surname><given-names>S</given-names></name><name><surname>Barrell</surname><given-names>BG</given-names></name></person-group><article-title xml:lang="en">Deciphering the biology of <italic>Mycobacterium tuberculosis</italic> from the complete genome sequence</article-title><source>Nature</source><year>1998</year><volume>393</volume><issue>6685</issue><fpage>537</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1038/31159</pub-id><pub-id pub-id-type="coi">1:CAS:528:DyaK1cXjvV2ksrY%3D</pub-id><pub-id pub-id-type="pmid">9634230</pub-id></mixed-citation></ref><ref id="CR28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cumming</surname><given-names>BM</given-names></name><name><surname>Rahman</surname><given-names>MA</given-names></name><name><surname>Lamprecht</surname><given-names>DA</given-names></name><name><surname>Rohde</surname><given-names>KH</given-names></name><name><surname>Saini</surname><given-names>V</given-names></name><name><surname>Adamson</surname><given-names>JH</given-names></name><name><surname>Russell</surname><given-names>DG</given-names></name><name><surname>Steyn</surname><given-names>AJC</given-names></name></person-group><article-title xml:lang="en"><italic>Mycobacterium tuberculosis</italic> arrests host cycle at the G1/S transition to establish long term infection</article-title><source>PLoS Pathog</source><year>2017</year><volume>13</volume><issue>7</issue><fpage>e1006490</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1006490</pub-id><pub-id pub-id-type="pmid">28708888</pub-id><pub-id pub-id-type="pmcid">5510850</pub-id></mixed-citation></ref><ref id="CR29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>EO</given-names></name><name><surname>Dullaghan</surname><given-names>EM</given-names></name><name><surname>Rand</surname><given-names>L</given-names></name></person-group><article-title xml:lang="en">Definition of the mycobacterial SOS box and use to identify LexA-regulated genes in <italic>Mycobacterium tuberculosis</italic></article-title><source>J Bacteriol</source><year>2002</year><volume>184</volume><issue>12</issue><fpage>3287</fpage><lpage>3295</lpage><pub-id pub-id-type="doi">10.1128/JB.184.12.3287-3295.2002</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD38XksV2ht7k%3D</pub-id><pub-id pub-id-type="pmid">12029045</pub-id><pub-id pub-id-type="pmcid">135081</pub-id></mixed-citation></ref><ref id="CR30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Rossi</surname><given-names>E</given-names></name><name><surname>Arrigo</surname><given-names>P</given-names></name><name><surname>Bellinzoni</surname><given-names>M</given-names></name><name><surname>Silva</surname><given-names>PA</given-names></name><name><surname>Martin</surname><given-names>C</given-names></name><name><surname>Ainsa</surname><given-names>JA</given-names></name><name><surname>Guglierame</surname><given-names>P</given-names></name><name><surname>Riccardi</surname><given-names>G</given-names></name></person-group><article-title xml:lang="en">The multidrug transporters belonging to major facilitator superfamily in <italic>Mycobacterium tuberculosis</italic></article-title><source>Mol Med</source><year>2002</year><volume>8</volume><fpage>714</fpage><lpage>724</lpage><pub-id pub-id-type="doi">10.1007/BF03402035</pub-id><pub-id pub-id-type="pmid">12520088</pub-id><pub-id pub-id-type="pmcid">2039957</pub-id></mixed-citation></ref><ref id="CR31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeJesus</surname><given-names>MA</given-names></name><name><surname>Gerrick</surname><given-names>ER</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Park</surname><given-names>SW</given-names></name><name><surname>Long</surname><given-names>JE</given-names></name><name><surname>Boutte</surname><given-names>CC</given-names></name><name><surname>Rubin</surname><given-names>EJ</given-names></name><name><surname>Schnappinger</surname><given-names>D</given-names></name><name><surname>Ehrt</surname><given-names>S</given-names></name><name><surname>Fortune</surname><given-names>SM</given-names></name><name><surname>Sassetti</surname><given-names>CM</given-names></name><name><surname>Ioerger</surname><given-names>TR</given-names></name></person-group><article-title xml:lang="en">Comprehensive essentiality analysis of the <italic>Mycobacterium tuberculosis</italic> genome via saturating transposon mutagenesis</article-title><source>mBio</source><year>2017</year><volume>8</volume><fpage>e02133</fpage><lpage>e02116</lpage><pub-id pub-id-type="doi">10.1128/mBio.02133-16</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXjsFeltbg%3D</pub-id><pub-id pub-id-type="pmid">28096490</pub-id><pub-id pub-id-type="pmcid">5241402</pub-id></mixed-citation></ref><ref id="CR32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denkin</surname><given-names>S</given-names></name><name><surname>Byrne</surname><given-names>S</given-names></name><name><surname>Jie</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Gene expression profiling analysis of <italic>Mycobacterium tuberculosis</italic> genes in response to salicylate</article-title><source>Arch Microbiol</source><year>2005</year><volume>184</volume><issue>3</issue><fpage>152</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1007/s00203-005-0037-9</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXht1SksbfM</pub-id><pub-id pub-id-type="pmid">16175359</pub-id></mixed-citation></ref><ref id="CR33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Driscoll</surname><given-names>MD</given-names></name><name><surname>Mclean</surname><given-names>KJ</given-names></name><name><surname>Levy</surname><given-names>C</given-names></name><name><surname>Mast</surname><given-names>N</given-names></name><name><surname>Pikuleva</surname><given-names>IA</given-names></name><name><surname>Lafite</surname><given-names>P</given-names></name><name><surname>Rigby</surname><given-names>ESJ</given-names></name><name><surname>Leys</surname><given-names>D</given-names></name><name><surname>Munro</surname><given-names>AW</given-names></name></person-group><article-title xml:lang="en">Structural and biochemical characterization of <italic>Mycobacterium tuberculosis</italic> CYP142 evidence for multiple cholesterol 27-hydroxylase activities in a human</article-title><source>J Biol Chem</source><year>2010</year><volume>285</volume><issue>49</issue><fpage>38270</fpage><lpage>38282</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.164293</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXhsVOku73O</pub-id><pub-id pub-id-type="pmid">20889498</pub-id><pub-id pub-id-type="pmcid">2992261</pub-id></mixed-citation></ref><ref id="CR34"><mixed-citation publication-type="other">Dubey VS, Sirakova TD, Cynamon MH, Kolattukudy PE (2003) Biochemical Function of msl5 (pks8plus pks17) in <italic>Mycobacterium tuberculosis</italic> H37Rv: Biosynthesis of Monomethyl Branched Unsaturated Fatty Acids. J Bacteriol. 185(15):4620–4625. <ext-link xlink:href="https://doi.org/10.1128/JB.185.15.4620-4625.2003" ext-link-type="doi">https://doi.org/10.1128/JB.185.15.4620-4625.2003</ext-link></mixed-citation></ref><ref id="CR35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duff</surname><given-names>JLC</given-names></name><name><surname>Breton</surname><given-names>JLJ</given-names></name><name><surname>Butt</surname><given-names>JN</given-names></name><name><surname>Armstrong</surname><given-names>FA</given-names></name><name><surname>Thomson</surname><given-names>AJ</given-names></name></person-group><article-title xml:lang="en">Novel redox chemistry of [3Fe-4S] clusters: electrochemical characterization of the all-Fe (II) form of the [3Fe-4S] cluster generated reversibly in various proteins and its spectroscopic investigation in <italic>Sulfolobus acidocaldarius</italic> ferredoxin</article-title><source>J Am Chem Soc</source><year>1996</year><volume>118</volume><issue>36</issue><fpage>8593</fpage><lpage>8603</lpage><pub-id pub-id-type="doi">10.1021/ja961465l</pub-id><pub-id pub-id-type="coi">1:CAS:528:DyaK28XltFeksLg%3D</pub-id></mixed-citation></ref><ref id="CR36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunford</surname><given-names>AJ</given-names></name><name><surname>McLean</surname><given-names>KJ</given-names></name><name><surname>Sabri</surname><given-names>M</given-names></name><name><surname>Seward</surname><given-names>HE</given-names></name><name><surname>Heyes</surname><given-names>DJ</given-names></name><name><surname>Scrutton</surname><given-names>NS</given-names></name><name><surname>Munro</surname><given-names>AW</given-names></name></person-group><article-title xml:lang="en">Rapid P450 heme iron reduction by laser photoexcitation of <italic>Mycobacterium tuberculosis</italic> CYP121 and CYP51B1</article-title><source>J Biol Chem</source><year>2007</year><volume>282</volume><issue>34</issue><fpage>24816</fpage><lpage>24824</lpage><pub-id pub-id-type="doi">10.1074/jbc.M702958200</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXpt1Sltr4%3D</pub-id><pub-id pub-id-type="pmid">17553785</pub-id></mixed-citation></ref><ref id="CR37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dutta</surname><given-names>NK</given-names></name><name><surname>Mehra</surname><given-names>S</given-names></name><name><surname>Didier</surname><given-names>PJ</given-names></name><name><surname>Roy</surname><given-names>CJ</given-names></name><name><surname>Doyle</surname><given-names>LA</given-names></name><name><surname>Alvarez</surname><given-names>X</given-names></name><name><surname>Ratterree</surname><given-names>M</given-names></name><name><surname>Be</surname><given-names>NA</given-names></name><name><surname>Lamichhane</surname><given-names>G</given-names></name><name><surname>Jain</surname><given-names>SK</given-names></name><name><surname>Lacey</surname><given-names>MR</given-names></name><name><surname>Lackner</surname><given-names>AA</given-names></name><name><surname>Kaushal</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">Genetic requirements for the survival of tubercle bacilli in primates</article-title><source>J Infect Dis</source><year>2010</year><volume>201</volume><issue>11</issue><fpage>1743</fpage><lpage>1752</lpage><pub-id pub-id-type="doi">10.1086/652497</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXnvFKitbk%3D</pub-id><pub-id pub-id-type="pmid">20394526</pub-id><pub-id pub-id-type="pmcid">2862080</pub-id></mixed-citation></ref><ref id="CR38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elliott</surname><given-names>SR</given-names></name><name><surname>Tischler</surname><given-names>AD</given-names></name></person-group><article-title xml:lang="en">Phosphate starvation: a novel signal that triggers ESX-5 secretion in <italic>Mycobacterium tuberculosis</italic></article-title><source>Mol Microbiol</source><year>2016</year><volume>100</volume><fpage>510</fpage><lpage>526</lpage><pub-id pub-id-type="doi">10.1111/mmi.13332</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XivVWnurk%3D</pub-id><pub-id pub-id-type="pmid">26800324</pub-id><pub-id pub-id-type="pmcid">4863468</pub-id></mixed-citation></ref><ref id="CR39"><mixed-citation publication-type="other">Ewen KM, Hannemann F, Khatri Y, Perlova O, Kappl R, Krug D, Hütterman J, Müller R, Bernhardt R (2009) Genome mining in <italic>Sorangium cellulosum</italic> so ce56: Indentification characterization of the homologous electron transfer proteins of a Myxobacterial cytochrome P450. J Biol Chem 284(42):28590–28598. <ext-link xlink:href="https://doi.org/10.1074/jbc.M109.021717" ext-link-type="doi">https://doi.org/10.1074/jbc.M109.021717</ext-link></mixed-citation></ref><ref id="CR40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>D</given-names></name><name><surname>Hong</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Sun</surname><given-names>B</given-names></name></person-group><article-title xml:lang="en">The LuxR family regulator Rv0195 modulates <italic>Mycobacterium tuberculosis</italic> dormancy and virulence</article-title><source>Tuberculosis</source><year>2013</year><volume>93</volume><issue>4</issue><fpage>425</fpage><lpage>431</lpage><pub-id pub-id-type="doi">10.1016/j.tube.2013.04.005</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXnslCntL0%3D</pub-id><pub-id pub-id-type="pmid">23673208</pub-id></mixed-citation></ref><ref id="CR41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>F</given-names></name><name><surname>Raimondi</surname><given-names>D</given-names></name><name><surname>Aliverti</surname><given-names>A</given-names></name><name><surname>Zanetti</surname><given-names>G</given-names></name></person-group><article-title xml:lang="en"><italic>Mycobacterium tuberculosis</italic> FprA, a novel bacterial NADPH-ferredoxin reductase</article-title><source>Eur J Biochem</source><year>2002</year><volume>269</volume><fpage>3005</fpage><lpage>3013</lpage><pub-id pub-id-type="doi">10.1046/j.1432-1033.2002.02989.x</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD38XltF2gsb4%3D</pub-id><pub-id pub-id-type="pmid">12071965</pub-id></mixed-citation></ref><ref id="CR42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>MA</given-names></name><name><surname>Plikaytis</surname><given-names>BB</given-names></name><name><surname>Shinnick</surname><given-names>TM</given-names></name></person-group><article-title xml:lang="en">Microarray analysis of the <italic>Mycobacterium tuberculosis</italic> transcriptional response to the acidic conditions found in phagosomes</article-title><source>J Bacteriol</source><year>2002</year><volume>184</volume><issue>14</issue><fpage>4025</fpage><lpage>4032</lpage><pub-id pub-id-type="doi">10.1128/JB.184.14.4025-4032.2002</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD38XltVykur8%3D</pub-id><pub-id pub-id-type="pmid">12081975</pub-id><pub-id pub-id-type="pmcid">135184</pub-id></mixed-citation></ref><ref id="CR43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fonvielle</surname><given-names>M</given-names></name><name><surname>Le Du</surname><given-names>MH</given-names></name><name><surname>Lequin</surname><given-names>O</given-names></name><name><surname>Lecoq</surname><given-names>A</given-names></name><name><surname>Jacquet</surname><given-names>M</given-names></name><name><surname>Thai</surname><given-names>R</given-names></name><name><surname>Dubois</surname><given-names>S</given-names></name><name><surname>Grach</surname><given-names>G</given-names></name><name><surname>Gondry</surname><given-names>M</given-names></name><name><surname>Belin</surname><given-names>P</given-names></name></person-group><article-title xml:lang="en">Substrate and reaction specificity of <italic>Mycobacterium tuberculosis</italic> cytochrome P450 CYP121: insights from biochemical studies and crystal structures</article-title><source>J Biol Chem</source><year>2013</year><volume>288</volume><issue>24</issue><fpage>17347</fpage><lpage>17359</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.443853</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXpsFamtbY%3D</pub-id><pub-id pub-id-type="pmid">23620594</pub-id><pub-id pub-id-type="pmcid">3682536</pub-id></mixed-citation></ref><ref id="CR44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname><given-names>DJ</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Wong</surname><given-names>SH</given-names></name><name><surname>Basudhar</surname><given-names>D</given-names></name><name><surname>De Voss</surname><given-names>JJ</given-names></name><name><surname>Ortiz de Montellano</surname><given-names>PR</given-names></name></person-group><article-title xml:lang="en">Cholesterol analogs with degradation-resistant alkyl side chains are effective <italic>Mycobacterium tuberculosis</italic> growth inhibitors</article-title><source>J Biol Chem</source><year>2016</year><volume>291</volume><issue>14</issue><fpage>7325</fpage><lpage>7333</lpage><pub-id pub-id-type="doi">10.1074/jbc.M115.708172</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28Xltlant7s%3D</pub-id><pub-id pub-id-type="pmid">26833565</pub-id><pub-id pub-id-type="pmcid">4817165</pub-id></mixed-citation></ref><ref id="CR45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gazaei</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en"><italic>Mycobacterium tuberculosis</italic> and lipids: insights into molecular mechanism from persistence to virulence</article-title><source>J Res Med Sci</source><year>2018</year><volume>23</volume><fpage>63</fpage><pub-id pub-id-type="doi">10.4103/jrms.JRMS_904_17</pub-id></mixed-citation></ref><ref id="CR46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geiman</surname><given-names>DE</given-names></name><name><surname>Raghunand</surname><given-names>TR</given-names></name><name><surname>Agarwal</surname><given-names>N</given-names></name><name><surname>Bishai</surname><given-names>WR</given-names></name></person-group><article-title xml:lang="en">Differential gene expression in response to exposure to antimycobacterial agents and other stress conditions among seven <italic>Mycobacterium tuberculosis</italic> whiB-like genes</article-title><source>Antimicrob Agents Chemother</source><year>2006</year><volume>50</volume><fpage>2836</fpage><lpage>2841</lpage><pub-id pub-id-type="doi">10.1128/AAC.00295-06</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28Xotlehtrk%3D</pub-id><pub-id pub-id-type="pmid">16870781</pub-id><pub-id pub-id-type="pmcid">1538666</pub-id></mixed-citation></ref><ref id="CR47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gokulan</surname><given-names>K</given-names></name><name><surname>O'Leary</surname><given-names>SE</given-names></name><name><surname>Russell</surname><given-names>WK</given-names></name><name><surname>Russell</surname><given-names>DH</given-names></name><name><surname>Lalgondar</surname><given-names>M</given-names></name><name><surname>Begley</surname><given-names>TP</given-names></name><name><surname>Ioerger</surname><given-names>TR</given-names></name><name><surname>Sacchettini</surname><given-names>JC</given-names></name></person-group><article-title xml:lang="en">Crystal structure of <italic>Mycobacterium tuberculosis</italic> polyketide synthase 11 (PKS11) reveals intermediates in the synthesis of methyl-branched alkylpyrones</article-title><source>J Biol Chem</source><year>2013</year><volume>288</volume><issue>23</issue><fpage>16484</fpage><lpage>16494</lpage><pub-id pub-id-type="doi">10.1074/jbc.M113.468892</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXptVCmurs%3D</pub-id><pub-id pub-id-type="pmid">23615910</pub-id><pub-id pub-id-type="pmcid">3675584</pub-id></mixed-citation></ref><ref id="CR48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>AJ</given-names></name><name><surname>Munro</surname><given-names>AW</given-names></name><name><surname>Cheesman</surname><given-names>MR</given-names></name><name><surname>Reid</surname><given-names>GA</given-names></name><name><surname>Von Wachenfeldt</surname><given-names>C</given-names></name><name><surname>Chapman</surname><given-names>SK</given-names></name></person-group><article-title xml:lang="en">Expression, purification and characterisation of a <italic>Bacillus subtilis</italic> ferredoxin: a potential electron transfer donor to cytochrome P450</article-title><source>BioI J Inorg Biochem</source><year>2003</year><volume>93</volume><issue>1–2</issue><fpage>92</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/S0162-0134(02)00456-7</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3sXltlahsQ%3D%3D</pub-id><pub-id pub-id-type="pmid">12538057</pub-id></mixed-citation></ref><ref id="CR49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffin</surname><given-names>JE</given-names></name><name><surname>Gawronski</surname><given-names>JD</given-names></name><name><surname>DeJesus</surname><given-names>MA</given-names></name><name><surname>Ioerger</surname><given-names>TR</given-names></name><name><surname>Akerley</surname><given-names>BJ</given-names></name><name><surname>Sassetti</surname><given-names>CM</given-names></name></person-group><article-title xml:lang="en">Phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism</article-title><source>PLoS Pathog</source><year>2011</year><volume>7</volume><issue>9</issue><fpage>e1002251</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1002251</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXhtlCmsbfN</pub-id><pub-id pub-id-type="pmid">21980284</pub-id><pub-id pub-id-type="pmcid">3182942</pub-id></mixed-citation></ref><ref id="CR50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guardiola-Diaz</surname><given-names>HM</given-names></name><name><surname>Foster</surname><given-names>LA</given-names></name><name><surname>Mushrush</surname><given-names>D</given-names></name><name><surname>Vaz</surname><given-names>AD</given-names></name></person-group><article-title xml:lang="en">Azole-antifungal binding to a novel cytochrome P450 from <italic>Mycobacterium tuberculosis</italic>: implications for treatment of tuberculosis</article-title><source>Biochem Pharmacol</source><year>2001</year><volume>61</volume><fpage>1463</fpage><lpage>1470</lpage><pub-id pub-id-type="doi">10.1016/S0006-2952(01)00571-8</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3MXjslers7g%3D</pub-id><pub-id pub-id-type="pmid">11377375</pub-id></mixed-citation></ref><ref id="CR51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guazzaroni</surname><given-names>ME</given-names></name><name><surname>Krell</surname><given-names>T</given-names></name><name><surname>Felipe</surname><given-names>A</given-names></name><name><surname>Ruiz</surname><given-names>R</given-names></name><name><surname>Meng</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Gallegos</surname><given-names>MT</given-names></name><name><surname>Ramos</surname><given-names>JL</given-names></name></person-group><article-title xml:lang="en">The multidrug efflux regulator TtgV recognizes a wide range of structurally different effectors in solution and complexed with target DNA: evidence from isothermal titration calorimetry</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>20887</fpage><lpage>20893</lpage><pub-id pub-id-type="doi">10.1074/jbc.M500783200</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXktlCltrc%3D</pub-id><pub-id pub-id-type="pmid">15767250</pub-id></mixed-citation></ref><ref id="CR52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hampshire</surname><given-names>T</given-names></name><name><surname>Soneji</surname><given-names>S</given-names></name><name><surname>Bacon</surname><given-names>J</given-names></name><name><surname>James</surname><given-names>BW</given-names></name><name><surname>Hinds</surname><given-names>J</given-names></name><name><surname>Laing</surname><given-names>K</given-names></name><name><surname>Stabler</surname><given-names>RA</given-names></name><name><surname>Marsh</surname><given-names>PD</given-names></name><name><surname>Butcher</surname><given-names>PD</given-names></name></person-group><article-title xml:lang="en">Stationary phase gene expression of <italic>Mycobacterium tuberculosis</italic> following a progressive nutrient depletion: a model for persistent organisms?</article-title><source>Tuberculosis</source><year>2004</year><volume>84</volume><issue>3–4</issue><fpage>228</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1016/j.tube.2003.12.010</pub-id><pub-id pub-id-type="pmid">15207492</pub-id></mixed-citation></ref><ref id="CR53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holsclaw</surname><given-names>CM</given-names></name><name><surname>Sogi</surname><given-names>KM</given-names></name><name><surname>Gilmore</surname><given-names>SA</given-names></name><name><surname>Schelle</surname><given-names>MW</given-names></name><name><surname>Leavell</surname><given-names>MD</given-names></name><name><surname>Bertozzi</surname><given-names>CR</given-names></name><name><surname>Leary</surname><given-names>JA</given-names></name></person-group><article-title xml:lang="en">Structural characterization of a novel sulfated menaquinone produced by stf3 from <italic>Mycobacterium tuberculosis</italic></article-title><source>ACS Chem Biol</source><year>2008</year><volume>3</volume><issue>10</issue><fpage>619</fpage><lpage>624</lpage><pub-id pub-id-type="doi">10.1021/cb800145r</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXht1GjsbvJ</pub-id><pub-id pub-id-type="pmid">18928249</pub-id></mixed-citation></ref><ref id="CR54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hudson</surname><given-names>SA</given-names></name><name><surname>McLean</surname><given-names>KJ</given-names></name><name><surname>Surade</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>YQ</given-names></name><name><surname>Leys</surname><given-names>D</given-names></name><name><surname>Ciulli</surname><given-names>A</given-names></name><name><surname>Munro</surname><given-names>AW</given-names></name><name><surname>Abell</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">Application of fragment screening and merging to the discovery of inhibitors of the <italic>Mycobacterium tuberculosis</italic> cytochrome P450 CYP121</article-title><source>Angew Chem Int Ed Eng</source><year>2012</year><volume>51</volume><issue>37</issue><fpage>9311</fpage><lpage>9316</lpage><pub-id pub-id-type="doi">10.1002/anie.201202544</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XhtFOmt7bO</pub-id></mixed-citation></ref><ref id="CR55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hudson</surname><given-names>SA</given-names></name><name><surname>Surade</surname><given-names>S</given-names></name><name><surname>Coyne</surname><given-names>AG</given-names></name><name><surname>McLean</surname><given-names>KJ</given-names></name><name><surname>Leys</surname><given-names>D</given-names></name><name><surname>Munro</surname><given-names>AW</given-names></name><name><surname>Abell</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">Overcoming the limitations of fragment merging: rescuing a strained merged fragment series targeting <italic>Mycobacterium tuberculosis</italic> CYP121</article-title><source>ChemMedChem</source><year>2013</year><volume>8</volume><issue>9</issue><fpage>1451</fpage><lpage>1456</lpage><pub-id pub-id-type="doi">10.1002/cmdc.201300219</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXpslCrtbw%3D</pub-id><pub-id pub-id-type="pmid">23788280</pub-id><pub-id pub-id-type="pmcid">4281926</pub-id></mixed-citation></ref><ref id="CR56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hudson</surname><given-names>SA</given-names></name><name><surname>Mashalidis</surname><given-names>EH</given-names></name><name><surname>Bender</surname><given-names>A</given-names></name><name><surname>McLean</surname><given-names>KJ</given-names></name><name><surname>Munro</surname><given-names>AW</given-names></name><name><surname>Abell</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">Biofragments: an approach towards predicting protein function using biologically related fragments and its application to <italic>Mycobacterium tuberculosis</italic> CYP126</article-title><source>Chembiochem</source><year>2014</year><volume>15</volume><issue>4</issue><fpage>549</fpage><lpage>555</lpage><pub-id pub-id-type="doi">10.1002/cbic.201300697</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXivFaiur0%3D</pub-id><pub-id pub-id-type="pmid">24677424</pub-id><pub-id pub-id-type="pmcid">4159592</pub-id></mixed-citation></ref><ref id="CR57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">The mycobacterial cell envelope-lipids</article-title><source>Cold Spring Harb Perspect Med</source><year>2014</year><volume>4</volume><issue>10</issue><fpage>a021105</fpage><pub-id pub-id-type="doi">10.1101/cshperspect.a021105</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXitVyit7%2FK</pub-id><pub-id pub-id-type="pmid">25104772</pub-id><pub-id pub-id-type="pmcid">4200213</pub-id></mixed-citation></ref><ref id="CR58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>SK</given-names></name><name><surname>Hernandez-Abanto</surname><given-names>SM</given-names></name><name><surname>Cheng</surname><given-names>QJ</given-names></name><name><surname>Singh</surname><given-names>P</given-names></name><name><surname>Ly</surname><given-names>LH</given-names></name><name><surname>Klinkenberg</surname><given-names>LG</given-names></name><name><surname>Morrison</surname><given-names>NE</given-names></name><name><surname>Converse</surname><given-names>PJ</given-names></name><name><surname>Nuermberger</surname><given-names>E</given-names></name><name><surname>Grosset</surname><given-names>J</given-names></name><name><surname>McMurray</surname><given-names>DN</given-names></name><name><surname>Karakousis</surname><given-names>PC</given-names></name><name><surname>Lamichhane</surname><given-names>G</given-names></name><name><surname>Bishai</surname><given-names>WR</given-names></name></person-group><article-title xml:lang="en">Accelerated detection of <italic>Mycobacterium tuberculosis</italic> genes essential for bacterial survival in Guinea pigs, compared with mice</article-title><source>J Infect Dis</source><year>2007</year><volume>195</volume><issue>11</issue><fpage>1634</fpage><lpage>1642</lpage><pub-id pub-id-type="doi">10.1086/517526</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXms1Ogtro%3D</pub-id><pub-id pub-id-type="pmid">17471433</pub-id></mixed-citation></ref><ref id="CR59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>F</given-names></name><name><surname>Lu</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Assessment of efflux pump gene expression in a clinical isolate <italic>Mycobacterium tuberculosis</italic> by real-time reverse transcription PCR</article-title><source>Microb Drug Resist</source><year>2008</year><volume>14</volume><issue>1</issue><fpage>7</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1089/mdr.2008.0772</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXjvFeht7k%3D</pub-id><pub-id pub-id-type="pmid">18321205</pub-id></mixed-citation></ref><ref id="CR60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>JB</given-names></name><name><surname>Kells</surname><given-names>PM</given-names></name><name><surname>Podust</surname><given-names>LM</given-names></name><name><surname>Ortiz de Montellano</surname><given-names>PR</given-names></name></person-group><article-title xml:lang="en">Biochemical and structural characterization of CYP124: a methyl-branched lipid omega-hydroxylase from <italic>Mycobacterium tuberculosis</italic></article-title><source>Proc Natl Acad Sci U S A</source><year>2009</year><volume>106</volume><issue>49</issue><fpage>20687</fpage><lpage>20692</lpage><pub-id pub-id-type="doi">10.1073/pnas.0907398106</pub-id><pub-id pub-id-type="pmid">19933331</pub-id><pub-id pub-id-type="pmcid">2791619</pub-id></mixed-citation></ref><ref id="CR61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>JB</given-names></name><name><surname>Ouellet</surname><given-names>H</given-names></name><name><surname>Ortiz de Montellano</surname><given-names>PR</given-names></name></person-group><article-title xml:lang="en">Functional redundancy of steroid C26-monooxygenase activity in <italic>Mycobacterium tuberculosis</italic> revealed by biochemical and genetic analysis</article-title><source>J Biol Chem</source><year>2010</year><volume>285</volume><fpage>36352</fpage><lpage>36360</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.161117</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXhsVWgsr7F</pub-id><pub-id pub-id-type="pmid">20843794</pub-id><pub-id pub-id-type="pmcid">2978563</pub-id></mixed-citation></ref><ref id="CR62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kavanagh</surname><given-names>ME</given-names></name><name><surname>Coyne</surname><given-names>AG</given-names></name><name><surname>McLean</surname><given-names>KJ</given-names></name><name><surname>James</surname><given-names>GG</given-names></name><name><surname>Levy</surname><given-names>CW</given-names></name><name><surname>Marino</surname><given-names>LB</given-names></name><name><surname>de Carvalho</surname><given-names>LP</given-names></name><name><surname>Chan</surname><given-names>DS</given-names></name><name><surname>Hudson</surname><given-names>SA</given-names></name><name><surname>Surade</surname><given-names>S</given-names></name><name><surname>Leys</surname><given-names>D</given-names></name><name><surname>Munro</surname><given-names>AW</given-names></name><name><surname>Abell</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">Fragment-based approaches to the development of <italic>Mycobacterium tuberculosis</italic> CYP121 inhibitors</article-title><source>J Med Chem</source><year>2016</year><volume>59</volume><issue>7</issue><fpage>3272</fpage><lpage>3302</lpage><pub-id pub-id-type="doi">10.1021/acs.jmedchem.6b00007</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XksV2gs7k%3D</pub-id><pub-id pub-id-type="pmid">27002486</pub-id><pub-id pub-id-type="pmcid">4835159</pub-id></mixed-citation></ref><ref id="CR63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Guengerich</surname><given-names>FP</given-names></name></person-group><article-title xml:lang="en">Cytochrome P450 activation of arylamines and heterocyclic amines</article-title><source>Annu Rev Pharmacol Toxicol</source><year>2005</year><volume>45</volume><fpage>27</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1146/annurev.pharmtox.45.120403.100010</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXisVWjtrg%3D</pub-id><pub-id pub-id-type="pmid">15822170</pub-id></mixed-citation></ref><ref id="CR64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koul</surname><given-names>A</given-names></name><name><surname>Vranckx</surname><given-names>L</given-names></name><name><surname>Dhar</surname><given-names>N</given-names></name><name><surname>Göhlmann</surname><given-names>HW</given-names></name><name><surname>Özdemir</surname><given-names>E</given-names></name><name><surname>Neefs</surname><given-names>JM</given-names></name><name><surname>Schulz</surname><given-names>M</given-names></name><name><surname>Lu</surname><given-names>P</given-names></name><name><surname>Mørtz</surname><given-names>E</given-names></name><name><surname>McKinney</surname><given-names>JD</given-names></name><name><surname>Andries</surname><given-names>K</given-names></name><name><surname>Bald</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">Delayed bactericidal response of <italic>Mycobacterium tuberculosis</italic> to bedaquiline involves remodelling of bacterial metabolism</article-title><source>Nat Commun</source><year>2014</year><volume>5</volume><fpage>3369</fpage><pub-id pub-id-type="doi">10.1038/ncomms4369</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXmtV2isLg%3D</pub-id><pub-id pub-id-type="pmid">24569628</pub-id><pub-id pub-id-type="pmcid">3948051</pub-id></mixed-citation></ref><ref id="CR65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>M</given-names></name><name><surname>Khan</surname><given-names>FG</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>R</given-names></name><name><surname>Faujdar</surname><given-names>J</given-names></name><name><surname>Sharma</surname><given-names>R</given-names></name><name><surname>Chauhan</surname><given-names>DS</given-names></name><name><surname>Singh</surname><given-names>R</given-names></name><name><surname>Magotra</surname><given-names>SK</given-names></name><name><surname>Khan</surname><given-names>IA</given-names></name></person-group><article-title xml:lang="en">Identification of <italic>Mycobacterium tuberculosis</italic> genes preferentially expressed during human infection</article-title><source>Microb Pathog</source><year>2011</year><volume>50</volume><issue>1</issue><fpage>31</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2010.10.003</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXhtF2luw%3D%3D</pub-id><pub-id pub-id-type="pmid">21035536</pub-id></mixed-citation></ref><ref id="CR66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamichhane</surname><given-names>G</given-names></name><name><surname>Zignol</surname><given-names>M</given-names></name><name><surname>Blades</surname><given-names>NJ</given-names></name><name><surname>Gelman</surname><given-names>DE</given-names></name><name><surname>Dougherty</surname><given-names>A</given-names></name><name><surname>Grosset</surname><given-names>J</given-names></name><name><surname>Broman</surname><given-names>KW</given-names></name><name><surname>Bishai</surname><given-names>WR</given-names></name></person-group><article-title xml:lang="en">A postgenomic method for predicting essential genes at subsaturation levels of mutagenesis: application to <italic>Mycobacterium tuberculosis</italic></article-title><source>Proc Natl Acad Sci U S A</source><year>2003</year><volume>100</volume><issue>12</issue><fpage>7213</fpage><lpage>7218</lpage><pub-id pub-id-type="doi">10.1073/pnas.1231432100</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3sXkslOmsro%3D</pub-id><pub-id pub-id-type="pmid">12775759</pub-id><pub-id pub-id-type="pmcid">165855</pub-id></mixed-citation></ref><ref id="CR67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamichhane</surname><given-names>G</given-names></name><name><surname>Tyagi</surname><given-names>S</given-names></name><name><surname>Bishai</surname><given-names>WR</given-names></name></person-group><article-title xml:lang="en">Designer arrays for defined mutant analysis to detect genes essential for survival of <italic>Mycobacterium tuberculosis</italic> in mouse lungs</article-title><source>Infect Immun</source><year>2005</year><volume>73</volume><issue>4</issue><fpage>2533</fpage><lpage>2540</lpage><pub-id pub-id-type="doi">10.1128/IAI.73.4.2533-2540.2005</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXjtFynsL8%3D</pub-id><pub-id pub-id-type="pmid">15784600</pub-id><pub-id pub-id-type="pmcid">1087429</pub-id></mixed-citation></ref><ref id="CR68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>W</given-names></name><name><surname>VanderVen</surname><given-names>BC</given-names></name><name><surname>Fahey</surname><given-names>RJ</given-names></name><name><surname>Russell</surname><given-names>DG</given-names></name></person-group><article-title xml:lang="en">Intracellular <italic>Mycobacterium tuberculosis</italic> exploits host derived fatty acids to limit metabolic stress</article-title><source>J Biol Chem</source><year>2013</year><volume>288</volume><issue>10</issue><fpage>6788</fpage><lpage>6800</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.445056</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXjslegsLg%3D</pub-id><pub-id pub-id-type="pmid">23306194</pub-id><pub-id pub-id-type="pmcid">3591590</pub-id></mixed-citation></ref><ref id="CR69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenaerts</surname><given-names>A</given-names></name><name><surname>Barry</surname><given-names>CE</given-names></name><name><surname>Dartroits</surname><given-names>V</given-names></name></person-group><article-title xml:lang="en">Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses</article-title><source>Immunol Rev</source><year>2015</year><volume>264</volume><issue>1</issue><fpage>288</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1111/imr.12252</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXjtVyhtb0%3D</pub-id><pub-id pub-id-type="pmid">25703567</pub-id><pub-id pub-id-type="pmcid">4368385</pub-id></mixed-citation></ref><ref id="CR70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lepesheva</surname><given-names>GI</given-names></name><name><surname>Hargrove</surname><given-names>TY</given-names></name><name><surname>Kleshchenko</surname><given-names>Y</given-names></name><name><surname>Nes</surname><given-names>WD</given-names></name><name><surname>Villalta</surname><given-names>F</given-names></name><name><surname>Waterman</surname><given-names>MR</given-names></name></person-group><article-title xml:lang="en">CYP51: a major drug target in the cytochrome P450 superfamily</article-title><source>Lipids</source><year>2008</year><volume>43</volume><fpage>1117</fpage><lpage>1125</lpage><pub-id pub-id-type="doi">10.1007/s11745-008-3225-y</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXhsVentrzI</pub-id><pub-id pub-id-type="pmid">18769951</pub-id><pub-id pub-id-type="pmcid">2715142</pub-id></mixed-citation></ref><ref id="CR71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Akiba</surname><given-names>M</given-names></name><name><surname>Sahin</surname><given-names>O</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name></person-group><article-title xml:lang="en">CmeR functions as a transcriptional repressor for the multidrug efflux pump CmeABC in <italic>Campylobacter jejuni</italic></article-title><source>Antimicrob Agents Chemother</source><year>2005</year><volume>49</volume><fpage>1067</fpage><lpage>1075</lpage><pub-id pub-id-type="doi">10.1128/AAC.49.3.1067-1075.2005</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXit12mur0%3D</pub-id><pub-id pub-id-type="pmid">15728904</pub-id><pub-id pub-id-type="pmcid">549222</pub-id></mixed-citation></ref><ref id="CR72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Little</surname><given-names>JW</given-names></name></person-group><article-title xml:lang="en">Mechanism of specific LexA cleavage: autodigestion and the role of RecA coprotease</article-title><source>Biochimie</source><year>1991</year><volume>73</volume><issue>4</issue><fpage>411</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.1016/0300-9084(91)90108-D</pub-id><pub-id pub-id-type="coi">1:CAS:528:DyaK3MXltVOiurk%3D</pub-id><pub-id pub-id-type="pmid">1911941</pub-id></mixed-citation></ref><ref id="CR73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Qiao</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Sang</surname><given-names>XH</given-names></name><name><surname>Li</surname><given-names>CR</given-names></name><name><surname>Jiang</surname><given-names>JD</given-names></name><name><surname>Yang</surname><given-names>XY</given-names></name><name><surname>You</surname><given-names>XF</given-names></name></person-group><article-title xml:lang="en">Recombinant expression and biochemical characterization of <italic>Mycobacterium tuberculosis</italic> 3Fe-4S ferredoxin Rv1786</article-title><source>Appl Microbiol Biotechnol</source><year>2017</year><volume>101</volume><issue>19</issue><fpage>7201</fpage><lpage>7212</lpage><pub-id pub-id-type="doi">10.1007/s00253-017-8454-7</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXhtlegsLbN</pub-id><pub-id pub-id-type="pmid">28812125</pub-id></mixed-citation></ref><ref id="CR74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKinney</surname><given-names>JD</given-names></name><name><surname>Höner zu Bentrup</surname><given-names>K</given-names></name><name><surname>Muñoz-Elías</surname><given-names>EJ</given-names></name><name><surname>Miczak</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>Chan</surname><given-names>WT</given-names></name><name><surname>Swenson</surname><given-names>D</given-names></name><name><surname>Sacchettini</surname><given-names>JC</given-names></name><name><surname>Jacobs</surname><given-names>WR</given-names><suffix>Jr</suffix></name><name><surname>Russell</surname><given-names>DG</given-names></name></person-group><article-title xml:lang="en">Persistence of <italic>Mycobacterium tuberculosis</italic> in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase</article-title><source>Nature</source><year>2000</year><volume>406</volume><fpage>735</fpage><lpage>738</lpage><pub-id pub-id-type="doi">10.1038/35021074</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3cXmt1Cgtbw%3D</pub-id><pub-id pub-id-type="pmid">10963599</pub-id></mixed-citation></ref><ref id="CR75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname><given-names>MJ</given-names></name><name><surname>Munro</surname><given-names>AW</given-names></name></person-group><article-title xml:lang="en">Structural biology and biochemistry of cytochrome P450 systems in <italic>Mycobacterium tuberculosis</italic></article-title><source>Drug Metab Rev</source><year>2008</year><volume>40</volume><issue>3</issue><fpage>427</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1080/03602530802186389</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXos12ht74%3D</pub-id><pub-id pub-id-type="pmid">18642141</pub-id></mixed-citation></ref><ref id="CR76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname><given-names>KJ</given-names></name><name><surname>Cheesman</surname><given-names>MR</given-names></name><name><surname>Rivers</surname><given-names>SL</given-names></name><name><surname>Richmond</surname><given-names>A</given-names></name><name><surname>Leys</surname><given-names>D</given-names></name><name><surname>Chapman</surname><given-names>SK</given-names></name><name><surname>Reid</surname><given-names>GA</given-names></name><name><surname>Price</surname><given-names>NC</given-names></name><name><surname>Kelly</surname><given-names>SM</given-names></name><name><surname>Clarkson</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>WE</given-names></name><name><surname>Munro</surname><given-names>AW</given-names></name></person-group><article-title xml:lang="en">Expression, purification and spectroscopic characterization of the cytochrome P450 CYP121 from <italic>Mycobacterium tuberculosis</italic></article-title><source>J Inorg Biochem</source><year>2002</year><volume>91</volume><issue>4</issue><fpage>527</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.1016/S0162-0134(02)00479-8</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD38XntVaqsr4%3D</pub-id><pub-id pub-id-type="pmid">12237220</pub-id></mixed-citation></ref><ref id="CR77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname><given-names>KJ</given-names></name><name><surname>Marshall</surname><given-names>KR</given-names></name><name><surname>Richmond</surname><given-names>A</given-names></name><name><surname>Hunter</surname><given-names>IS</given-names></name><name><surname>Fowler</surname><given-names>K</given-names></name><name><surname>Kieser</surname><given-names>T</given-names></name><name><surname>Gurcha</surname><given-names>SS</given-names></name><name><surname>Besra</surname><given-names>GS</given-names></name><name><surname>Munro</surname><given-names>AW</given-names></name></person-group><article-title xml:lang="en">Azole antifungals are potent inhibitors of cytochrome P450 mono-oxygenases and bacterial growth in mycobacteria and streptomycetes</article-title><source>Microbiology</source><year>2002</year><volume>148</volume><issue>Pt 10</issue><fpage>2937</fpage><lpage>2949</lpage><pub-id pub-id-type="doi">10.1099/00221287-148-10-2937</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD38XotFymtrg%3D</pub-id><pub-id pub-id-type="pmid">12368427</pub-id></mixed-citation></ref><ref id="CR78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname><given-names>KJ</given-names></name><name><surname>Sabri</surname><given-names>M</given-names></name><name><surname>Marshall</surname><given-names>KR</given-names></name><name><surname>Lawson</surname><given-names>RJ</given-names></name><name><surname>Lewis</surname><given-names>DG</given-names></name><name><surname>Clift</surname><given-names>D</given-names></name><name><surname>Baldin</surname><given-names>PR</given-names></name><name><surname>Dunford</surname><given-names>AJ</given-names></name><name><surname>Warman</surname><given-names>AJ</given-names></name><name><surname>McVey</surname><given-names>JP</given-names></name><name><surname>Quinn</surname><given-names>AM</given-names></name><name><surname>Sutcliffe</surname><given-names>MJ</given-names></name><name><surname>Scrutton</surname><given-names>NS</given-names></name><name><surname>Munro</surname><given-names>AW</given-names></name></person-group><article-title xml:lang="en">Biodiversity of cytochrome P450 redox systems</article-title><source>Biochem Soc Trans</source><year>2005</year><volume>33</volume><issue>Pt4</issue><fpage>796</fpage><lpage>801</lpage><pub-id pub-id-type="doi">10.1042/BST0330796</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXmvFSmsLw%3D</pub-id><pub-id pub-id-type="pmid">16042601</pub-id></mixed-citation></ref><ref id="CR79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname><given-names>KJ</given-names></name><name><surname>Warman</surname><given-names>AJ</given-names></name><name><surname>Seward</surname><given-names>HE</given-names></name><name><surname>Marshall</surname><given-names>KR</given-names></name><name><surname>Girvan</surname><given-names>HM</given-names></name><name><surname>Cheesman</surname><given-names>MR</given-names></name><name><surname>Waterman</surname><given-names>MR</given-names></name><name><surname>Munro</surname><given-names>AW</given-names></name></person-group><article-title xml:lang="en">Biophysical characterization of the sterol demethylase P450 from <italic>Mycobacterium tuberculosis</italic>, its cognate ferredoxin, and their interactions</article-title><source>Biochemistry</source><year>2006</year><volume>45</volume><issue>27</issue><fpage>8427</fpage><lpage>8443</lpage><pub-id pub-id-type="doi">10.1021/bi0601609</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28XlsFOqs74%3D</pub-id><pub-id pub-id-type="pmid">16819841</pub-id></mixed-citation></ref><ref id="CR80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname><given-names>KJ</given-names></name><name><surname>Clift</surname><given-names>D</given-names></name><name><surname>Lewis</surname><given-names>DG</given-names></name><name><surname>Sabri</surname><given-names>M</given-names></name><name><surname>Balding</surname><given-names>PR</given-names></name><name><surname>Sutcliffe</surname><given-names>MJ</given-names></name><name><surname>Leys</surname><given-names>D</given-names></name><name><surname>Munro</surname><given-names>AW</given-names></name></person-group><article-title xml:lang="en">The preponderance of P450s in the <italic>Mycobacterium tuberculosis</italic> genome</article-title><source>Trends Microbiol</source><year>2006</year><volume>14</volume><issue>5</issue><fpage>220</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2006.03.002</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28Xks1ektL8%3D</pub-id><pub-id pub-id-type="pmid">16581251</pub-id></mixed-citation></ref><ref id="CR81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname><given-names>KJ</given-names></name><name><surname>Dunford</surname><given-names>AJ</given-names></name><name><surname>Neeli</surname><given-names>R</given-names></name><name><surname>Driscoll</surname><given-names>MD</given-names></name><name><surname>Munro</surname><given-names>AW</given-names></name></person-group><article-title xml:lang="en">Structure, function and drug targeting in <italic>Mycobacterium tuberculosis</italic> cytochrome P450 systems</article-title><source>Arch Biochem Biophys</source><year>2007</year><volume>464</volume><fpage>228</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1016/j.abb.2007.03.026</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXovFylt7s%3D</pub-id><pub-id pub-id-type="pmid">17482138</pub-id></mixed-citation></ref><ref id="CR82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname><given-names>KJ</given-names></name><name><surname>Carroll</surname><given-names>P</given-names></name><name><surname>Lewis</surname><given-names>DG</given-names></name><name><surname>Dunford</surname><given-names>AJ</given-names></name><name><surname>Seward</surname><given-names>HE</given-names></name><name><surname>Neeli</surname><given-names>R</given-names></name><name><surname>Chesman</surname><given-names>LM</given-names></name><name><surname>Douglas</surname><given-names>P</given-names></name><name><surname>Smith</surname><given-names>WE</given-names></name><name><surname>Rosenkrands</surname><given-names>I</given-names></name><name><surname>Cole</surname><given-names>ST</given-names></name><name><surname>Munro</surname><given-names>AW</given-names></name></person-group><article-title xml:lang="en">Characterization of active site structure in CYP121: a cytochrome P450 essential for viability of <italic>Mycobacterium tuberculosis</italic> H37Rv</article-title><source>J Biol Chem</source><year>2008</year><volume>283</volume><issue>48</issue><fpage>33406</fpage><lpage>33416</lpage><pub-id pub-id-type="doi">10.1074/jbc.M802115200</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXhsVSgt73M</pub-id><pub-id pub-id-type="pmid">18818197</pub-id><pub-id pub-id-type="pmcid">2662266</pub-id></mixed-citation></ref><ref id="CR83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname><given-names>KJ</given-names></name><name><surname>Lafite</surname><given-names>P</given-names></name><name><surname>Levy</surname><given-names>C</given-names></name><name><surname>Cheesman</surname><given-names>MR</given-names></name><name><surname>Mast</surname><given-names>N</given-names></name><name><surname>Pikuleva</surname><given-names>IA</given-names></name><name><surname>Leys</surname><given-names>D</given-names></name><name><surname>Munro</surname><given-names>AW</given-names></name></person-group><article-title xml:lang="en">The structure of <italic>Mycobacterium tuberculosis</italic> CYP125: molecular basis for cholesterol binding in a P450 needed for host infection</article-title><source>J Biol Chem</source><year>2009</year><volume>284</volume><fpage>35524</fpage><lpage>35533</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.032706</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXhsFCqurnK</pub-id><pub-id pub-id-type="pmid">19846552</pub-id><pub-id pub-id-type="pmcid">2790982</pub-id></mixed-citation></ref><ref id="CR84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname><given-names>KJ</given-names></name><name><surname>Belcher</surname><given-names>J</given-names></name><name><surname>Driscoll</surname><given-names>MD</given-names></name><name><surname>Fernandez</surname><given-names>CC</given-names></name><name><surname>Le Van</surname><given-names>D</given-names></name><name><surname>Bui</surname><given-names>S</given-names></name><name><surname>Golovanova</surname><given-names>M</given-names></name><name><surname>Munro</surname><given-names>AW</given-names></name></person-group><article-title xml:lang="en">The <italic>Mycobacterium tuberculosis</italic> cytochromes P450: physiology, biochemistry &amp; molecular intervention</article-title><source>Future Med Chem</source><year>2010</year><volume>2</volume><issue>8</issue><fpage>1339</fpage><lpage>1353</lpage><pub-id pub-id-type="doi">10.4155/fmc.10.216</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXhtVGru7vJ</pub-id><pub-id pub-id-type="pmid">21426022</pub-id></mixed-citation></ref><ref id="CR85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>RP</given-names></name><name><surname>Nguyen</surname><given-names>L</given-names></name><name><surname>Gatfield</surname><given-names>J</given-names></name><name><surname>Visconti</surname><given-names>K</given-names></name><name><surname>Nguyen</surname><given-names>K</given-names></name><name><surname>Schnappinger</surname><given-names>D</given-names></name><name><surname>Ehrt</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Heifets</surname><given-names>L</given-names></name><name><surname>Pieters</surname><given-names>J</given-names></name><name><surname>Schoolnik</surname><given-names>G</given-names></name><name><surname>Thompson</surname><given-names>CJ</given-names></name></person-group><article-title xml:lang="en">Ancestral antibiotic resistance in <italic>Mycobacterium tuberculosis</italic></article-title><source>Proc Natl Acad Sci U S A</source><year>2005</year><volume>102</volume><issue>34</issue><fpage>12200</fpage><lpage>12205</lpage><pub-id pub-id-type="doi">10.1073/pnas.0505446102</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXps1yqs7Y%3D</pub-id><pub-id pub-id-type="pmid">16103351</pub-id><pub-id pub-id-type="pmcid">1186028</pub-id></mixed-citation></ref><ref id="CR86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mougous</surname><given-names>JD</given-names></name><name><surname>Senaratne</surname><given-names>RH</given-names></name><name><surname>Petzold</surname><given-names>CJ</given-names></name><name><surname>Jain</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>DH</given-names></name><name><surname>Schelle</surname><given-names>MW</given-names></name><name><surname>Leavell</surname><given-names>MD</given-names></name><name><surname>Cox</surname><given-names>JS</given-names></name><name><surname>Leary</surname><given-names>JA</given-names></name><name><surname>Riley</surname><given-names>LW</given-names></name><name><surname>Bertozzi</surname><given-names>CR</given-names></name></person-group><article-title xml:lang="en">A sulfated metabolite produced by stf3 negatively regulates the virulence of <italic>Mycobacterium tuberculosis</italic></article-title><source>Proc Natl Acad Sci U S A</source><year>2006</year><volume>103</volume><issue>11</issue><fpage>4258</fpage><lpage>4263</lpage><pub-id pub-id-type="doi">10.1073/pnas.0510861103</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28XivFWhsrk%3D</pub-id><pub-id pub-id-type="pmid">16537518</pub-id><pub-id pub-id-type="pmcid">1449680</pub-id></mixed-citation></ref><ref id="CR87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Namouchi</surname><given-names>A</given-names></name><name><surname>Gómez-Muñoz</surname><given-names>M</given-names></name><name><surname>Frye</surname><given-names>SA</given-names></name><name><surname>Moen</surname><given-names>LV</given-names></name><name><surname>Rognes</surname><given-names>T</given-names></name><name><surname>Tønjum</surname><given-names>T</given-names></name><name><surname>Balasingham</surname><given-names>SV</given-names></name></person-group><article-title xml:lang="en">The <italic>Mycobacterium tuberculosis</italic> transcriptional landscape under genotoxic stress</article-title><source>BMC Genomics</source><year>2016</year><volume>17</volume><issue>1</issue><fpage>791</fpage><pub-id pub-id-type="doi">10.1186/s12864-016-3132-1</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXitVSls7jK</pub-id><pub-id pub-id-type="pmid">27724857</pub-id><pub-id pub-id-type="pmcid">5057432</pub-id></mixed-citation></ref><ref id="CR88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikaido</surname><given-names>H</given-names></name><name><surname>Jarlier</surname><given-names>V</given-names></name></person-group><article-title xml:lang="en">Permeability of the mycobacterial cell wall</article-title><source>Res Microbiol</source><year>1991</year><volume>142</volume><issue>4</issue><fpage>437</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1016/0923-2508(91)90117-S</pub-id><pub-id pub-id-type="coi">1:CAS:528:DyaK3MXmsFWltbk%3D</pub-id><pub-id pub-id-type="pmid">1871430</pub-id></mixed-citation></ref><ref id="CR89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishioka</surname><given-names>WK</given-names></name><name><surname>Welsh</surname><given-names>RM</given-names></name></person-group><article-title xml:lang="en">Susceptibility to cytotoxic T lymphocyte-induced apoptosis is a function of the proliferative status of the target</article-title><source>J Exp Med</source><year>1994</year><volume>179</volume><issue>2</issue><fpage>769</fpage><lpage>774</lpage><pub-id pub-id-type="doi">10.1084/jem.179.2.769</pub-id><pub-id pub-id-type="coi">1:STN:280:DyaK2c7isFSlsA%3D%3D</pub-id><pub-id pub-id-type="pmid">8294885</pub-id></mixed-citation></ref><ref id="CR90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortega Ugalde</surname><given-names>S</given-names></name><name><surname>de Koning</surname><given-names>CP</given-names></name><name><surname>Wallraven</surname><given-names>K</given-names></name><name><surname>Bruyneel</surname><given-names>B</given-names></name><name><surname>Vermeulen</surname><given-names>NPE</given-names></name><name><surname>Grossmann</surname><given-names>TN</given-names></name><name><surname>Bitter</surname><given-names>W</given-names></name><name><surname>Commandeur</surname><given-names>JNM</given-names></name><name><surname>Vos</surname><given-names>JC</given-names></name></person-group><article-title xml:lang="en">Linking cytochrome P450 enzymes from <italic>Mycobacterium tuberculosis</italic> to their cognate ferredoxin partners</article-title><source>Appl Microbiol Biotechnol</source><year>2018</year><volume>102</volume><fpage>9231</fpage><lpage>9242</lpage><pub-id pub-id-type="doi">10.1007/s00253-018-9299-4</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXhsFOgsL%2FM</pub-id><pub-id pub-id-type="pmid">30136203</pub-id><pub-id pub-id-type="pmcid">6208970</pub-id></mixed-citation></ref><ref id="CR91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortega Ugalde</surname><given-names>S</given-names></name><name><surname>Luirink</surname><given-names>RA</given-names></name><name><surname>Geerke</surname><given-names>DP</given-names></name><name><surname>Vermeulen</surname><given-names>NPE</given-names></name><name><surname>Bitter</surname><given-names>W</given-names></name><name><surname>Commandeur</surname><given-names>JNM</given-names></name></person-group><article-title xml:lang="en">Engineering a self-sufficient <italic>Mycobacterium tuberculosis</italic> CYP130 by gene fusion with the reductase-domain of CYP102A1 from <italic>Bacillus megaterium</italic></article-title><source>J Inorg Biochem</source><year>2018</year><volume>180</volume><fpage>47</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.jinorgbio.2017.12.003</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXhvFGlsLbF</pub-id><pub-id pub-id-type="pmid">29232638</pub-id></mixed-citation></ref><ref id="CR92"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortiz de Montellano</surname><given-names>PR</given-names></name></person-group><article-title xml:lang="en">Potential drug targets in the <italic>Mycobacterium tuberculosis</italic> cytochrome P450 system</article-title><source>J Inorg Biochem</source><year>2018</year><volume>180</volume><fpage>235</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1016/j.jinorgbio.2018.01.010</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXhtFKkurs%3D</pub-id><pub-id pub-id-type="pmid">29352597</pub-id><pub-id pub-id-type="pmcid">5801126</pub-id></mixed-citation></ref><ref id="CR93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ouellet</surname><given-names>H</given-names></name><name><surname>Johnston</surname><given-names>JB</given-names></name><name><surname>Ortiz de Montellano</surname><given-names>PR</given-names></name></person-group><article-title xml:lang="en">The <italic>Mycobacterium tuberculosis</italic> cytochrome P450 system</article-title><source>Arch Biochem Biophys</source><year>2010</year><volume>493</volume><issue>1</issue><fpage>82</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1016/j.abb.2009.07.011</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXhsFyitbnN</pub-id><pub-id pub-id-type="pmid">19635450</pub-id></mixed-citation></ref><ref id="CR94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ouellet</surname><given-names>H</given-names></name><name><surname>Guan</surname><given-names>S</given-names></name><name><surname>Johnston</surname><given-names>JB</given-names></name><name><surname>Chow</surname><given-names>ED</given-names></name><name><surname>Kells</surname><given-names>PM</given-names></name><name><surname>Burlingame</surname><given-names>AL</given-names></name><name><surname>Cox</surname><given-names>JS</given-names></name><name><surname>Podust</surname><given-names>LM</given-names></name><name><surname>Ortiz de Montellano</surname><given-names>PR</given-names></name></person-group><article-title xml:lang="en"><italic>Mycobacterium tuberculosis</italic> CYP125A1, a steroid C27 monooxygenase that detoxifies intracellularly generated cholest-4-en-3-one</article-title><source>Mol Microbiol</source><year>2010</year><volume>77</volume><issue>3</issue><fpage>730</fpage><lpage>742</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2010.07243.x</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXhtVOhtrzM</pub-id><pub-id pub-id-type="pmid">20545858</pub-id><pub-id pub-id-type="pmcid">2909382</pub-id></mixed-citation></ref><ref id="CR95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ouellet</surname><given-names>H</given-names></name><name><surname>Kells</surname><given-names>PM</given-names></name><name><surname>Ortiz de Montellano</surname><given-names>PR</given-names></name><name><surname>Podust</surname><given-names>LM</given-names></name></person-group><article-title xml:lang="en">Reverse type I inhibitor of <italic>Mycobacterium tuberculosis</italic> CYP125A1</article-title><source>Bioorg Med Chem Lett</source><year>2011</year><volume>21</volume><issue>1</issue><fpage>332</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2010.11.007</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXhs1SqsbzK</pub-id><pub-id pub-id-type="pmid">21109436</pub-id></mixed-citation></ref><ref id="CR96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>DK</given-names></name><name><surname>Lee</surname><given-names>KE</given-names></name><name><surname>Baek</surname><given-names>CH</given-names></name><name><surname>Kim</surname><given-names>IH</given-names></name><name><surname>Kwon</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>WK</given-names></name><name><surname>Lee</surname><given-names>KH</given-names></name><name><surname>Kim</surname><given-names>BS</given-names></name><name><surname>Choi</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>KS</given-names></name></person-group><article-title xml:lang="en">Cyclo(Phe-pro) modulates the expression of ompU in Vibrio spp</article-title><source>J Bacteriol</source><year>2006</year><volume>188</volume><issue>6</issue><fpage>2214</fpage><lpage>2221</lpage><pub-id pub-id-type="doi">10.1128/JB.188.6.2214-2221.2006</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28XisFKmsb4%3D</pub-id><pub-id pub-id-type="pmid">16513751</pub-id><pub-id pub-id-type="pmcid">1428137</pub-id></mixed-citation></ref><ref id="CR97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parvez</surname><given-names>M</given-names></name><name><surname>Qhanya</surname><given-names>LB</given-names></name><name><surname>Mthakathi</surname><given-names>NT</given-names></name><name><surname>Kgosiemang</surname><given-names>IK</given-names></name><name><surname>Bamal</surname><given-names>HD</given-names></name><name><surname>Pagadala</surname><given-names>NS</given-names></name><name><surname>Xie</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Theron</surname><given-names>CW</given-names></name><name><surname>Monyaki</surname><given-names>R</given-names></name><name><surname>Raselemane</surname><given-names>SC</given-names></name><name><surname>Salewe</surname><given-names>V</given-names></name><name><surname>Mongale</surname><given-names>BL</given-names></name><name><surname>Matowane</surname><given-names>RG</given-names></name><name><surname>Abdalla</surname><given-names>SM</given-names></name><name><surname>Booi</surname><given-names>WI</given-names></name><name><surname>van Wyk</surname><given-names>M</given-names></name><name><surname>Olivier</surname><given-names>D</given-names></name><name><surname>Boucher</surname><given-names>CE</given-names></name><name><surname>Nelson</surname><given-names>DR</given-names></name><name><surname>Tuszynski</surname><given-names>JA</given-names></name><name><surname>Blackburn</surname><given-names>JM</given-names></name><name><surname>Yu</surname><given-names>JH</given-names></name><name><surname>Mashele</surname><given-names>SS</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Syed</surname><given-names>K</given-names></name></person-group><article-title xml:lang="en">Molecular evolutionary dynamics of cytochrome P450 monooxygenases across kingdoms: special focus on mycobacterial P450s</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><fpage>33099</fpage><pub-id pub-id-type="doi">10.1038/srep33099</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XhsV2rsLjI</pub-id><pub-id pub-id-type="pmid">27616185</pub-id><pub-id pub-id-type="pmcid">5018878</pub-id></mixed-citation></ref><ref id="CR98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>EJR</given-names></name><name><surname>Ma</surname><given-names>S</given-names></name><name><surname>Sherman</surname><given-names>DR</given-names></name><name><surname>Baliga</surname><given-names>NS</given-names></name></person-group><article-title xml:lang="en">Network analysis identifies Rv0324 and Rv0880 as regulators of bedaquiline tolerance in <italic>Mycobacterium tuberculosis</italic></article-title><source>Nat Microbiol</source><year>2016</year><volume>1</volume><issue>8</issue><fpage>16078</fpage><pub-id pub-id-type="doi">10.1038/nmicrobiol.2016.78</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXkvF2ju7c%3D</pub-id><pub-id pub-id-type="pmid">27573104</pub-id><pub-id pub-id-type="pmcid">5010021</pub-id></mixed-citation></ref><ref id="CR99"><mixed-citation publication-type="other">Pisu D, Provvedi R, Espinosa DM, Payan JB, Boldrin F, Palù G, Hernandez-Pando R, Manganelli R (2017) The alternative sigma factors SigE and SigB are involved in tolerance and persistence to antitubercular drugs. Antimicrob Agents Chemother 61(12). <ext-link xlink:href="https://doi.org/10.1128/AAC.01596-17" ext-link-type="doi">https://doi.org/10.1128/AAC.01596-17</ext-link></mixed-citation></ref><ref id="CR100"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Podust</surname><given-names>LM</given-names></name><name><surname>Poulos</surname><given-names>TL</given-names></name><name><surname>Waterman</surname><given-names>MR</given-names></name></person-group><article-title xml:lang="en">Crystal structure of cytochrome P450 14α-sterol demethylase (CYP51) from <italic>Mycobacterium tuberculosis</italic> in complex with azole inhibitors</article-title><source>Proc Natl Acad Sci U S A</source><year>2001</year><volume>98</volume><issue>6</issue><fpage>3068</fpage><lpage>3073</lpage><pub-id pub-id-type="doi">10.1073/pnas.061562898</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3MXit1amu7Y%3D</pub-id><pub-id pub-id-type="pmid">11248033</pub-id><pub-id pub-id-type="pmcid">30608</pub-id></mixed-citation></ref><ref id="CR101"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Podust</surname><given-names>LM</given-names></name><name><surname>Yermalitskaya</surname><given-names>LV</given-names></name><name><surname>Lepesheva</surname><given-names>GI</given-names></name><name><surname>Podust</surname><given-names>VN</given-names></name><name><surname>Dalmasso</surname><given-names>EA</given-names></name><name><surname>Waterman</surname><given-names>MR</given-names></name></person-group><article-title xml:lang="en">Estriol bound and ligand-free structures of sterol 14alpha-demethylase</article-title><source>Structure</source><year>2004</year><volume>12</volume><issue>11</issue><fpage>1937</fpage><lpage>1945</lpage><pub-id pub-id-type="doi">10.1016/j.str.2004.08.009</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2cXpsVOrsrs%3D</pub-id><pub-id pub-id-type="pmid">15530358</pub-id></mixed-citation></ref><ref id="CR102"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Podust</surname><given-names>LM</given-names></name><name><surname>Ouellet</surname><given-names>H</given-names></name><name><surname>von Kries</surname><given-names>JP</given-names></name><name><surname>Ortiz de Montellano</surname><given-names>PR</given-names></name></person-group><article-title xml:lang="en">Interaction of <italic>Mycobacterium tuberculosis</italic> CYP130 with heterocyclic Arylamines</article-title><source>J Biol Chem</source><year>2009</year><volume>284</volume><issue>37</issue><fpage>25211</fpage><lpage>25219</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.017632</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXhtV2nsb7K</pub-id><pub-id pub-id-type="pmid">19605350</pub-id><pub-id pub-id-type="pmcid">2757224</pub-id></mixed-citation></ref><ref id="CR103"><mixed-citation publication-type="other">Rengarajan J, Bloom BR, Rubin EJ (2005) Genome-wide requirements for <italic>Mycobacterium tuberculosis</italic> adaptation and survival in macrophages. Proc Natl Acad Sci U S A 102(23):8327–8332. <ext-link xlink:href="https://doi.org/10.1073/pnas.0503272102" ext-link-type="doi">https://doi.org/10.1073/pnas.0503272102</ext-link></mixed-citation></ref><ref id="CR104"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ricagno</surname><given-names>S</given-names></name><name><surname>De Rosa</surname><given-names>M</given-names></name><name><surname>Aliverti</surname><given-names>A</given-names></name><name><surname>Zanetti</surname><given-names>G</given-names></name><name><surname>Bolognesi</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">The crystal structure of FdxA, a 7Fe ferredoxin from <italic>Mycobacterium smegmatis</italic></article-title><source>Biochem Biophys Res Commun</source><year>2007</year><volume>360</volume><issue>1</issue><fpage>97</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2007.06.013</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXntFamtbY%3D</pub-id><pub-id pub-id-type="pmid">17577575</pub-id></mixed-citation></ref><ref id="CR105"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riccardi</surname><given-names>G</given-names></name><name><surname>Pasca</surname><given-names>MR</given-names></name></person-group><article-title xml:lang="en">Trends in discovery of new drugs for tuberculosis therapy</article-title><source>J Antibiot</source><year>2014</year><volume>67</volume><issue>9</issue><fpage>655</fpage><lpage>659</lpage><pub-id pub-id-type="doi">10.1038/ja.2014.109</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXhs1ehsrvE</pub-id><pub-id pub-id-type="pmid">25095807</pub-id></mixed-citation></ref><ref id="CR106"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rimal</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>SW</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Oh</surname><given-names>TJ</given-names></name></person-group><article-title xml:lang="en">Understanding of real alternative redox partner of <italic>Streptomyces peucetius DoxA</italic>: prediction and validation using in silico and in vitro analyses</article-title><source>Arch Biochem Biophys</source><year>2015</year><volume>585</volume><fpage>64</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.abb.2015.08.019</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXhsFGhtbjJ</pub-id><pub-id pub-id-type="pmid">26334717</pub-id></mixed-citation></ref><ref id="CR107"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rustad</surname><given-names>TR</given-names></name><name><surname>Minch</surname><given-names>KJ</given-names></name><name><surname>Ma</surname><given-names>S</given-names></name><name><surname>Winkler</surname><given-names>JK</given-names></name><name><surname>Hobbs</surname><given-names>S</given-names></name><name><surname>Hickey</surname><given-names>M</given-names></name><name><surname>Brabant</surname><given-names>W</given-names></name><name><surname>Turkarslan</surname><given-names>S</given-names></name><name><surname>Price</surname><given-names>ND</given-names></name><name><surname>Baliga</surname><given-names>NS</given-names></name><name><surname>Sherman</surname><given-names>DR</given-names></name></person-group><article-title xml:lang="en">Mapping and manipulating the <italic>Mycobacterium tuberculosis</italic> transcriptome using a transcription factor overexpression-derived regulatory network</article-title><source>Genome Biol</source><year>2014</year><volume>15</volume><issue>11</issue><fpage>502</fpage><pub-id pub-id-type="doi">10.1186/s13059-014-0502-3</pub-id><pub-id pub-id-type="pmid">25380655</pub-id><pub-id pub-id-type="pmcid">4249609</pub-id></mixed-citation></ref><ref id="CR108"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sassetti</surname><given-names>CM</given-names></name><name><surname>Rubin</surname><given-names>EJ</given-names></name></person-group><article-title xml:lang="en">Genetic requirements for mycobacterial survival during infection</article-title><source>Proc Natl Acad Sci U S A</source><year>2003</year><volume>100</volume><issue>22</issue><fpage>12989</fpage><lpage>12994</lpage><pub-id pub-id-type="doi">10.1073/pnas.2134250100</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3sXoslKmsrc%3D</pub-id><pub-id pub-id-type="pmid">14569030</pub-id><pub-id pub-id-type="pmcid">240732</pub-id></mixed-citation></ref><ref id="CR109"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sassetti</surname><given-names>CM</given-names></name><name><surname>Boyd</surname><given-names>DH</given-names></name><name><surname>Rubin</surname><given-names>EJ</given-names></name></person-group><article-title xml:lang="en">Genes required for microbial growth in defined high density mutagenesis</article-title><source>Mol Microbiol</source><year>2003</year><volume>48</volume><issue>1</issue><fpage>77</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2958.2003.03425.x</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3sXislOrsLY%3D</pub-id><pub-id pub-id-type="pmid">12657046</pub-id></mixed-citation></ref><ref id="CR110"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saxena</surname><given-names>P</given-names></name><name><surname>Yadav</surname><given-names>G</given-names></name><name><surname>Mohanty</surname><given-names>D</given-names></name><name><surname>Gokhale</surname><given-names>RS</given-names></name></person-group><article-title xml:lang="en">A new family of type III polyketide synthases in <italic>Mycobacterium tuberculosis</italic></article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>44780</fpage><lpage>44790</lpage><pub-id pub-id-type="doi">10.1074/jbc.M306714200</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3sXoslWlsLk%3D</pub-id><pub-id pub-id-type="pmid">12941968</pub-id></mixed-citation></ref><ref id="CR111"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sayes</surname><given-names>F</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Di Luca</surname><given-names>M</given-names></name><name><surname>Simeone</surname><given-names>R</given-names></name><name><surname>Degaiffier</surname><given-names>N</given-names></name><name><surname>Fiette</surname><given-names>L</given-names></name><name><surname>Esin</surname><given-names>S</given-names></name><name><surname>Brosch</surname><given-names>R</given-names></name><name><surname>Bottai</surname><given-names>D</given-names></name><name><surname>Leclerc</surname><given-names>C</given-names></name><name><surname>Majlessi</surname><given-names>L</given-names></name></person-group><article-title xml:lang="en">Strong immunogenicity and cross-reactivity of <italic>Mycobacterium tuberculosis</italic> ESX-5 type VII secretion: encoded PE-PPE proteins predicts vaccine potential</article-title><source>Cell Host Microbe</source><year>2012</year><volume>11</volume><fpage>352</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2012.03.003</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XlvFygsL8%3D</pub-id><pub-id pub-id-type="pmid">22520463</pub-id></mixed-citation></ref><ref id="CR112"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schnappinger</surname><given-names>D</given-names></name><name><surname>Ehrt</surname><given-names>S</given-names></name><name><surname>Voskuil</surname><given-names>MI</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Mangan</surname><given-names>JA</given-names></name><name><surname>Monahan</surname><given-names>IM</given-names></name><name><surname>Dolganov</surname><given-names>G</given-names></name><name><surname>Efron</surname><given-names>B</given-names></name><name><surname>Butcher</surname><given-names>PD</given-names></name><name><surname>Nathan</surname><given-names>C</given-names></name><name><surname>Schoolnik</surname><given-names>GK</given-names></name></person-group><article-title xml:lang="en">Transcriptional adaptation of <italic>Mycobacterium tuberculosis</italic> within macrophages: insights into the phagosomal environment</article-title><source>J Exp Med</source><year>2003</year><volume>198</volume><issue>5</issue><fpage>693</fpage><lpage>704</lpage><pub-id pub-id-type="doi">10.1084/jem.20030846</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3sXntFeqt78%3D</pub-id><pub-id pub-id-type="pmid">12953091</pub-id><pub-id pub-id-type="pmcid">2194186</pub-id></mixed-citation></ref><ref id="CR113"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sevrioukova</surname><given-names>IF</given-names></name></person-group><article-title xml:lang="en">Redox-dependent structural reorganization in putidaredoxin, a vertebrate-type [2Fe-2S] ferredoxin from <italic>Pseudomonas putida</italic></article-title><source>J Mol Biol</source><year>2005</year><volume>347</volume><issue>3</issue><fpage>607</fpage><lpage>621</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2005.01.047</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXitFChtro%3D</pub-id><pub-id pub-id-type="pmid">15755454</pub-id></mixed-citation></ref><ref id="CR114"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seward</surname><given-names>HE</given-names></name><name><surname>Roujeinikova</surname><given-names>A</given-names></name><name><surname>McLean</surname><given-names>KJ</given-names></name><name><surname>Munro</surname><given-names>AW</given-names></name><name><surname>Leys</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">Crystal structure of the <italic>Mycobacterium tuberculosis</italic> P450 CYP121-fluconazole complex reveals new azole drug-P450 binding mode</article-title><source>J Biol Chem</source><year>2006</year><volume>281</volume><issue>51</issue><fpage>39437</fpage><lpage>39443</lpage><pub-id pub-id-type="doi">10.1074/jbc.M607665200</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28XhtlagsLbF</pub-id><pub-id pub-id-type="pmid">17028183</pub-id></mixed-citation></ref><ref id="CR115"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sherman</surname><given-names>DR</given-names></name><name><surname>Voskuil</surname><given-names>M</given-names></name><name><surname>Schnappinger</surname><given-names>D</given-names></name><name><surname>Liao</surname><given-names>R</given-names></name><name><surname>Harrell</surname><given-names>MI</given-names></name><name><surname>Schoolnik</surname><given-names>GK</given-names></name></person-group><article-title xml:lang="en">Regulation of the <italic>Mycobacterium tuberculosis</italic> hypoxic response gene encoding alpha-crystallin</article-title><source>Proc Natl Acad Sci U S A</source><year>2001</year><volume>98</volume><issue>13</issue><fpage>7534</fpage><lpage>7539</lpage><pub-id pub-id-type="doi">10.1073/pnas.121172498</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3MXkslWls7o%3D</pub-id><pub-id pub-id-type="pmid">11416222</pub-id><pub-id pub-id-type="pmcid">34703</pub-id></mixed-citation></ref><ref id="CR116"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiloh</surname><given-names>MU</given-names></name><name><surname>Manzanillo</surname><given-names>P</given-names></name><name><surname>Cox</surname><given-names>JS</given-names></name></person-group><article-title xml:lang="en"><italic>Mycobacterium tuberculosis</italic> senses host-derived carbon monoxide during macrophage infection</article-title><source>Cell Host Microbe</source><year>2008</year><volume>3</volume><issue>5</issue><fpage>323</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2008.03.007</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXmsVyjurk%3D</pub-id><pub-id pub-id-type="pmid">18474359</pub-id><pub-id pub-id-type="pmcid">2873178</pub-id></mixed-citation></ref><ref id="CR117"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siddiqi</surname><given-names>N</given-names></name><name><surname>Das</surname><given-names>R</given-names></name><name><surname>Pathak</surname><given-names>N</given-names></name><name><surname>Banerjee</surname><given-names>S</given-names></name><name><surname>Ahmed</surname><given-names>N</given-names></name><name><surname>Katoch</surname><given-names>VM</given-names></name><name><surname>Hasnain</surname><given-names>SE</given-names></name></person-group><article-title xml:lang="en"><italic>Mycobacterium tuberculosis</italic> isolate with a distinct genomic identity overexpresses a tap-like efflux pump</article-title><source>Infection</source><year>2004</year><volume>32</volume><issue>2</issue><fpage>109</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1007/s15010-004-3097-x</pub-id><pub-id pub-id-type="coi">1:STN:280:DC%2BD2c7mtlGhsw%3D%3D</pub-id><pub-id pub-id-type="pmid">15057575</pub-id></mixed-citation></ref><ref id="CR118"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>GR</given-names></name><name><surname>Wernisch</surname><given-names>L</given-names></name><name><surname>Stabler</surname><given-names>R</given-names></name><name><surname>Mangan</surname><given-names>JA</given-names></name><name><surname>Hinds</surname><given-names>J</given-names></name><name><surname>Laing</surname><given-names>KG</given-names></name><name><surname>Young</surname><given-names>DB</given-names></name><name><surname>Butcher</surname><given-names>PD</given-names></name></person-group><article-title xml:lang="en">Dissection of the heat-shock response in <italic>Mycobacterium tuberculosis</italic> using mutants and microarrays</article-title><source>Microbiology</source><year>2002</year><volume>148</volume><fpage>3129</fpage><lpage>3138</lpage><pub-id pub-id-type="doi">10.1099/00221287-148-10-3129</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD38XotFymtLs%3D</pub-id><pub-id pub-id-type="pmid">12368446</pub-id></mixed-citation></ref><ref id="CR119"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talaat</surname><given-names>AM</given-names></name><name><surname>Lyons</surname><given-names>R</given-names></name><name><surname>Howard</surname><given-names>ST</given-names></name><name><surname>Johnston</surname><given-names>SA</given-names></name></person-group><article-title xml:lang="en">The temporal expression profile of <italic>Mycobacterium tuberculosis</italic> infection in mice</article-title><source>Proc Natl Acad Sci U S A</source><year>2004</year><volume>101</volume><issue>13</issue><fpage>4602</fpage><lpage>4607</lpage><pub-id pub-id-type="doi">10.1073/pnas.0306023101</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2cXjtFKisL4%3D</pub-id><pub-id pub-id-type="pmid">15070764</pub-id><pub-id pub-id-type="pmcid">384793</pub-id></mixed-citation></ref><ref id="CR120"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>ten Bokum</surname><given-names>AM</given-names></name><name><surname>Movahedzadeh</surname><given-names>F</given-names></name><name><surname>Frita</surname><given-names>R</given-names></name><name><surname>Bancroft</surname><given-names>GJ</given-names></name><name><surname>Stoker</surname><given-names>NG</given-names></name></person-group><article-title xml:lang="en">The case for hypervirulence through gene deletion in <italic>Mycobacterium tuberculosis</italic></article-title><source>Trends Microbiol</source><year>2008</year><volume>16</volume><issue>9</issue><fpage>436</fpage><lpage>441</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2008.06.003</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXhtVOhsr7N</pub-id><pub-id pub-id-type="pmid">18701293</pub-id></mixed-citation></ref><ref id="CR121"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trower</surname><given-names>MK</given-names></name><name><surname>Lenstra</surname><given-names>R</given-names></name><name><surname>Omer</surname><given-names>C</given-names></name><name><surname>Buchholz</surname><given-names>SE</given-names></name><name><surname>Sariaslani</surname><given-names>FS</given-names></name></person-group><article-title xml:lang="en">Cloning, nucleotide sequence determination and expression of the genes encoding cytochrome P450soy (soyC) and ferredoxin soy (soyB) from <italic>Streptomyces griseus</italic></article-title><source>Mol Microbiol</source><year>1993</year><volume>7</volume><issue>6</issue><fpage>1024</fpage><lpage>1025</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.1993.tb01194.x</pub-id><pub-id pub-id-type="coi">1:CAS:528:DyaK3sXkvVyit7o%3D</pub-id><pub-id pub-id-type="pmid">8483414</pub-id></mixed-citation></ref><ref id="CR122"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>VanderVen</surname><given-names>BC</given-names></name><name><surname>Fahey</surname><given-names>RJ</given-names></name><name><surname>Lee</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Abramovitch</surname><given-names>RB</given-names></name><name><surname>Memmott</surname><given-names>C</given-names></name><name><surname>Crowe</surname><given-names>AM</given-names></name><name><surname>Eltis</surname><given-names>LD</given-names></name><name><surname>Perola</surname><given-names>E</given-names></name><name><surname>Deininger</surname><given-names>DD</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Locher</surname><given-names>CP</given-names></name><name><surname>Russell</surname><given-names>DG</given-names></name></person-group><article-title xml:lang="en">Novel inhibitors of cholesterol degradation in <italic>Mycobacterium tuberculosis</italic> reveal how the bacterium's metabolism is constrained by the intracellular environment</article-title><source>PLoS Pathog</source><year>2015</year><volume>11</volume><issue>2</issue><fpage>e1004679</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1004679</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXjt1Gluro%3D</pub-id><pub-id pub-id-type="pmid">25675247</pub-id><pub-id pub-id-type="pmcid">4335503</pub-id></mixed-citation></ref><ref id="CR123"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voskuil</surname><given-names>ML</given-names></name><name><surname>Visconti</surname><given-names>KC</given-names></name><name><surname>Schoolnik</surname><given-names>GK</given-names></name></person-group><article-title xml:lang="en"><italic>Mycobacterium tuberculosis</italic> gene expression during adaptation to stationary phase and low-oxygen dormancy</article-title><source>Tuberculosis</source><year>2004</year><volume>84</volume><fpage>218</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1016/j.tube.2004.02.003</pub-id><pub-id pub-id-type="coi">1:STN:280:DC%2BD2czgs1KjtQ%3D%3D</pub-id><pub-id pub-id-type="pmid">15207491</pub-id></mixed-citation></ref><ref id="CR124"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warrilow</surname><given-names>AG</given-names></name><name><surname>Parker</surname><given-names>JE</given-names></name><name><surname>Kelly</surname><given-names>DE</given-names></name><name><surname>Kelly</surname><given-names>SL</given-names></name></person-group><article-title xml:lang="en">Azole affinity of sterol 14alpha-demethylase (CYP51) enzymes from <italic>Candida albicans</italic> and <italic>Homo sapiens</italic></article-title><source>Antimicrob Agents Chemother</source><year>2013</year><volume>57</volume><issue>3</issue><fpage>1352</fpage><lpage>1360</lpage><pub-id pub-id-type="doi">10.1128/AAC.02067-12</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXltV2htL8%3D</pub-id><pub-id pub-id-type="pmid">23274672</pub-id><pub-id pub-id-type="pmcid">3591892</pub-id></mixed-citation></ref><ref id="CR125"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weerdenburg</surname><given-names>EM</given-names></name><name><surname>Abdallah</surname><given-names>AM</given-names></name><name><surname>Rangkuti</surname><given-names>F</given-names></name><name><surname>Abd El Ghany</surname><given-names>M</given-names></name><name><surname>Otto</surname><given-names>TD</given-names></name><name><surname>Adroub</surname><given-names>SA</given-names></name><name><surname>Molenaar</surname><given-names>D</given-names></name><name><surname>Ummels</surname><given-names>R</given-names></name><name><surname>ter Veen</surname><given-names>K</given-names></name><name><surname>van Stempvoort</surname><given-names>G</given-names></name><name><surname>van der Sar</surname><given-names>AM</given-names></name><name><surname>Ali</surname><given-names>S</given-names></name><name><surname>Langridge</surname><given-names>GC</given-names></name><name><surname>Thomson</surname><given-names>NR</given-names></name><name><surname>Pain</surname><given-names>A</given-names></name><name><surname>Bitter</surname><given-names>W</given-names></name></person-group><article-title xml:lang="en">Genome-wide transposon mutagenesis indicates that <italic>Mycobacterium marinum</italic> customizes its virulence mechanisms for survival and replication in different hosts</article-title><source>Infect Immun</source><year>2015</year><volume>83</volume><fpage>1778</fpage><lpage>1788</lpage><pub-id pub-id-type="doi">10.1128/IAI.03050-14</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXnvVehsb8%3D</pub-id><pub-id pub-id-type="pmid">25690095</pub-id><pub-id pub-id-type="pmcid">4399070</pub-id></mixed-citation></ref><ref id="CR126"><mixed-citation publication-type="other">Wilburn KM, Fieweger RA, VanderVen BC (2018) Cholesterol and fatty acids grease the wheels of <italic>Mycobacterium tuberculosis</italic> pathogenesis. Pathog Dis 76(2). <ext-link xlink:href="https://doi.org/10.1093/femspd/fty021" ext-link-type="doi">https://doi.org/10.1093/femspd/fty021</ext-link></mixed-citation></ref><ref id="CR127"><mixed-citation publication-type="other">World Health Organization, 2018. Global tuberculosis report 2018. World Health Organization, Geneva. <ext-link xlink:href="http://apps.who.int/iris/bitstream/handle/10665/274453/9789241565646-eng.pdf?ua=1" ext-link-type="url">http://apps.who.int/iris/bitstream/handle/10665/274453/9789241565646-eng.pdf?ua=1</ext-link>. Accessed 29 Nov 2018</mixed-citation></ref><ref id="CR128"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>G</given-names></name><name><surname>Ni</surname><given-names>Z</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Wei</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>F</given-names></name></person-group><article-title xml:lang="en">Screening essential genes of <italic>Mycobacterium tuberculosis</italic> with the pathway enrichment method</article-title><source>Mol Biol Rep</source><year>2014</year><volume>41</volume><issue>11</issue><fpage>7639</fpage><lpage>7644</lpage><pub-id pub-id-type="doi">10.1007/s11033-014-3654-z</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXht1yksL3L</pub-id><pub-id pub-id-type="pmid">25098602</pub-id></mixed-citation></ref><ref id="CR129"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zanno</surname><given-names>A</given-names></name><name><surname>Kwiatkowski</surname><given-names>N</given-names></name><name><surname>Vaz</surname><given-names>ADN</given-names></name><name><surname>Guardiola-Diaz</surname><given-names>HM</given-names></name></person-group><article-title xml:lang="en">MT FdR: a ferredoxin reductase from <italic>Mycobacterium tuberculosis</italic> that couples to MT CYP51</article-title><source>Biochim Biophys Acta Bioenerg</source><year>2005</year><volume>1707</volume><fpage>157</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1016/j.bbabio.2004.11.010</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXjs1Cqtbc%3D</pub-id></mixed-citation></ref><ref id="CR130"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>YJ</given-names></name><name><surname>Ioerger</surname><given-names>TR</given-names></name><name><surname>Huttenhower</surname><given-names>C</given-names></name><name><surname>Long</surname><given-names>JE</given-names></name><name><surname>Sassetti</surname><given-names>CM</given-names></name><name><surname>Sacchettini</surname><given-names>JC</given-names></name><name><surname>Rubin</surname><given-names>EJ</given-names></name></person-group><article-title xml:lang="en">Global assessment of genomic regions required for growth in <italic>Mycobacterium tuberculosis</italic></article-title><source>PLoS Pathog</source><year>2012</year><volume>8</volume><issue>9</issue><fpage>e1002946</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1002946</pub-id><pub-id pub-id-type="pmid">23028335</pub-id><pub-id pub-id-type="pmcid">3460630</pub-id></mixed-citation></ref><ref id="CR131"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Cui</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name></person-group><article-title xml:lang="en">Identification of novel efflux proteins Rv0191, Rv3756c, Rv3008, and Rv1667c involved in pyrazinamide resistance in <italic>Mycobacterium tuberculosis</italic></article-title><source>Antimicrob Agents Chemother</source><year>2017</year><volume>61</volume><issue>8</issue><fpage>e00940</fpage><lpage>e00917</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXitVSktbfL</pub-id><pub-id pub-id-type="doi">10.1128/AAC.00940-17</pub-id><pub-id pub-id-type="pmid">28584158</pub-id><pub-id pub-id-type="pmcid">5527661</pub-id></mixed-citation></ref></ref-list></ref-list><notes notes-type="Misc"><title>Publisher’s note</title><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></notes></back></article></records><facets><facet name="subject"><facet-value count="1">Biotechnology</facet-value><facet-value count="1">Life Sciences</facet-value><facet-value count="1">Microbial Genetics and Genomics</facet-value><facet-value count="1">Microbiology</facet-value></facet><facet name="keyword"><facet-value count="1">
                Mycobacterium tuberculosis
              </facet-value><facet-value count="1">Antibiotic exposure response</facet-value><facet-value count="1">Cytochrome P450</facet-value><facet-value count="1">Essentiality</facet-value><facet-value count="1">Redox partners</facet-value><facet-value count="1">Stress response</facet-value></facet><facet name="pub"><facet-value count="1">Applied Microbiology and Biotechnology</facet-value></facet><facet name="year"><facet-value count="1">2019</facet-value></facet><facet name="country"><facet-value count="1">Netherlands</facet-value><facet-value count="1">United States</facet-value></facet><facet name="type"><facet-value count="1">Journal</facet-value></facet></facets></response>
